Patent Grant
10384029
Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference herein and made a part of the present disclosure.
The present invention relates to a nasal interface for providing a flow of respiratory gases to a user.
Nasal interfaces for providing a flow of gases to a user include interfaces having nasal outlets with pillows that provide a seal at a user's nostrils, and nasal cannulae interfaces where the nasal outlets are nasal prongs for insertion into a user's nostrils. A typical nasal cannula interface includes a plenum portion and entry tubing or a manifold section (symmetric or single sided) and a pair of open-ended prongs which protrude from the plenum or manifold and extend into the nostrils of the user in use to supply the patient with gases. Generally, but not always, the prongs of a nasal cannula are sized and shaped so that they do not seal against the nostrils of a patient. Nasal cannulae are used because these are advantageous in certain situations. For example, in circumstances where a patient is breathing normally, but requires supplementary gases such as oxygen. The existing market for nasal cannula includes devices suitable for delivery of gases in the 0 to 5 liters per minute range. These devices are typically supported by a double entry lumen of small diameter (2-3 mm range) that supply both sides of the nasal cannula and provides even or equal airflow to each nasal prong. These devices typically deliver dry gas flows of between 0 to 5 liters per minute, when the patient is self-breathing, and it is not necessary for the cannula prongs to seal against the nares of a user. A user will entrain the supplementary gases provided from the cannula along with atmospheric air as they inhale normally.
An example of a nasal cannula interface that seals against the nostrils is the Nasal-Aire interface made by Innomed, where gases are provided to the interface and the prongs by conduits or hoses that extend from the users nose across their cheeks, over their ears and around the back of their head.
WO 2008/060295 describes a non-sealing cannula that includes nasal prongs. There are many configurations described. The nasal prongs are adapted to deliver air to a patient's nasal passage and the different embodiments of prongs described include various external features, and may include passages that pass through the wall of the prongs to allow sensors or similar to measure the properties of gases in the prongs.
In this specification where reference has been made to patent specifications, other external documents, or other sources of information, this is generally for the purpose of providing a context for discussing the features of the invention. Unless specifically stated otherwise, reference to such external documents is not to be construed as an admission that such documents, or such sources of information, in any jurisdiction, are prior art, or form part of the common general knowledge in the art.
It is an object of the present invention to provide an improved nasal interface or to at least provide the industry or public with a useful choice.
In one aspect, the present invention consists in a nasal interface for use in a system for providing a flow of respiratory gases to a user, the nasal interface comprising: a body made from a pliable first material, the body having an inlet for connection to a conduit providing a flow of gases and at least one nasal outlet comprising a tubular structure for interfacing with a user's nostril in use, the at least one nasal outlet fluidly connected to the inlet, a frame made from a second material more rigid than the first material, the frame attached to or integrally formed with the body, the frame adapted to engage the conduit to secure the conduit relative to the body.
Preferably the frame has a first projection for engaging the conduit to secure the conduit to the frame.
Preferably the frame comprises a second projection for engaging the body to removably secure the body to the frame thereby securing the conduit relative to the body.
Preferably the frame is permanently attached to the body.
Preferably the body is overmoulded to the frame.
Preferably the first projection is a first flange substantially perpendicular to the longitudinal axis of the conduit for engaging about a circumference of the conduit near an end of the conduit, the first flange having a hole open on one side for receiving the conduit, the diameter of the hole being matched to an external diameter of said circumference, the width of the opening being less than the external diameter of said circumference, in use the frame being elastically deformed during attachment to the conduit.
Preferably the body comprises a recess for receiving the second projection.
Preferably the second projection is a second flange substantially perpendicular to the longitudinal axis of the conduit, and the recess is a corresponding slot for receiving the second flange.
Preferably the inlet of the body is an aperture for receiving the end of the conduit, in use a rim around the aperture being sandwiched between the first flange and a surface extending radially from the conduit adjacent said circumference, sealingly engaging the inlet to the conduit.
Preferably the body has an annular groove extending about the aperture for receiving the surface extending radially from the conduit.
Preferably the interface further comprises the conduit for providing a flow of gases to the inlet, the conduit having a first radially extending surface and a second radially extending surface, the first flange engaging the conduit about a circumference between the first and second radially extending surfaces, the first flange being captured in a direction along the axis of the conduit between the first and second radially extending surfaces.
Preferably the nasal interface includes the conduit, the conduit connecting to the body from below the body, the inlet being directly below the nasal outlets.
Preferably the body comprises a pair of side arms, each side arm extending from a central portion of the body to in use pass across and contact a user's upper lip region
Preferably in use, a distal end of each side arm rests substantially on the front of a user's face adjacent a side of the user's nose.
Preferably the body is an integrally formed unit comprising the inlet, nasal outlets and side arms.
Preferably a connection is formed in each side arm for connecting the nasal interface to headgear for holding the nasal interface in place on a user's head in use.
Preferably the frame comprises a pair of side arms, each side arm extending from a central portion of the frame to in use pass across a user's upper lip region.
Preferably in use, a distal end of each frame side arm rests substantially on the front of a user's face adjacent a side of the user's nose.
Preferably the frame is an integrally formed unit comprising the central portion, the first and second projections and the side arms.
Preferably in use the body arms rest in between a user's face and the frame side arms.
Preferably the distal end of each frame side arm is provided with a connection for attachment to head gear for holding the interface in place on a user's face in use.
Preferably the connection is a slot in a said side arm for receiving a head gear strap through to attach the head gear to the side arm, the slot being substantially perpendicular to a longitudinal axis of the side arm.
Preferably each body side arm comprises a retainer for attaching the body side arm to the corresponding frame side arm.
Preferably the connection is a slot for receiving a head gear strap through to attach the head gear to the side arm, the slot being substantially perpendicular to a longitudinal axis of the side arm, and the retainer is a tab located adjacent a distal end of the body side arm, in use the tab being received in said slot.
Preferably each connection is a quick release connector provided with a said side arm, the quick release connector adapted to quickly disconnect the head gear from at least one side.
Preferably the nasal interface is a nasal cannula, the at least one nasal outlet is a prong for insertion into a user's nostril in use.
Alternatively the at least one nasal outlet is a nasal pillow for providing a seal against a user's nostril in use.
In another aspect, the present invention consists in a nasal cannula for use in a system for providing a flow of respiratory gases to a user, the nasal cannula comprising: a body comprising an inlet for receiving a flow of gases and at least one nasal prong for insertion into a user's nostril in use, the at least one nasal prong fluidly connected to the inlet, an area for contacting the user's face or nose or both, in use contact between the area and the user's nose or face or both setting the position of the prongs forwardly in the user's nostrils to provide a gap between a rear extent of the nasal prong and the back of the user's nostril.
Preferably the size of the gap between the rear extent of the prong and the back of the user's nostril is at least 50% of the diameter of the prong.
Preferably the size of the gap between the rear extent of the prong and the back of the user's nostril is at least 100% of the diameter of the prong.
Preferably the area contacts an upper lip region of the user, in use headgear pulling the area against the user's upper lip region.
Preferably the area extends across most of the user's upper lip region.
Preferably the area contacts the user's septum.
Preferably the area contacts the junction between the user's septum and the user's upper lip, in use the headgear pulling the cannula against said junction.
Preferably in use contact between the area and the user's nose or face or both sets the angle of the prongs in the user's nasal passage so that the flow of gases are directed towards a front wall of the user's nasal passage.
Preferably the nasal prong is curved about a centre of curvature located towards the front of the user's nose so that the prong curves towards the front of the user's nasal passage in use.
Preferably wherein the nasal prong is substantially straight.
Preferably the body comprises a pair of side arms, each side arm in use passing across a user's upper lip region.
Preferably in use, a distal end of each side arm rests substantially on the front of a user's face adjacent a side of the user's nose.
Preferably the body is an integrally formed unit comprising the inlet, nasal prongs and side arms.
Preferably a connection is formed in each side arm for connecting the nasal cannula to headgear for holding the nasal cannula in place on a user's head in use.
Preferably the body comprises a bridge portion, in use the bridge portion supporting the cannula on a user's upper lip region, the bridge portion providing a channel between the bridge portion and a rear extent of the nasal prongs, the channel providing a path for exhaled gases to flow.
Preferably the cross section of the channel is adjustable to adjust the distance the nasal prongs are spaced from the area of the body in contact with a user's upper lip region in use.
Preferably the cross section of the channel is adjustable by a screw received in a screw thread.
Preferably the nasal cannula comprises a single nasal prong for insertion into a user's nostril in use, the user's other nostril being vacant, and the body comprising a channel aligned with the vacant nostril for exhaled gases to flow through.
In another aspect, the present invention consists in a nasal cannula for use in a system for providing a flow of respiratory gases to a user, the nasal cannula comprising: a body comprising an inlet for receiving a flow of gases and at least one nasal prong for insertion into a user's nostril in use, the at least one nasal prong fluidly connected to the inlet, the cannula comprising an area in contact with the user's face or nose or both, in use contact between the area and the user's nose or face or both setting the angle of the prongs in the user's nasal passage so that the flow of gases are directed towards a front wall of the user's nasal passage.
Preferably in use a longitudinal axis of each nasal prong at the tip of each nasal prong is parallel to or angled forward of a plane, the plane being vertical when the user is in a standing position with the user's head held level.
Preferably each prong has an outlet and in use the general plane of the outlet is parallel to the bottom wall of the user's nasal passage or angled forwardly towards the front wall of the user's nasal passage.
Preferably each prong has an outlet, and the outlet is not visible when the nasal prong is viewed from the rear and along a line parallel to where the bottom of the user's nasal passage would be relative to the prong in use.
Preferably each nasal prong has an outlet, and in use the outlet of each nasal prong faces the front wall of the user's nasal passage.
Preferably the area contacts an upper lip region of the user, in use headgear pulling the area against the user's upper lip.
Preferably the nasal prong is angled or curved so that a longitudinal axis of the prong at the tip of the prong is parallel to or angled forwardly of the plane of the area in contact with the user's upper lip region.
Preferably the angle between the longitudinal axis of the prong at the tip of the prong and the plane of the area in contact with the user's upper lip is at least 10°.
Preferably the area extends across most of the user's upper lip region.
Preferably the area contacts the user's septum.
Preferably the area contacts the junction between the user's septum and the user's upper lip, in use the headgear pulling the cannula against said junction.
Preferably in use contact between the area and the user's nose or face or both setting the position of the prongs forwardly in the user's nostrils to provide a gap between a rear extend of the nasal prong and the back of the user's nostril.
Preferably the size of the gap between the rear extent of the prong and the back of the user's nostril is at least 50% of the diameter of the prong.
Preferably the size of the gap between the rear extent of the prong and the back of the user's nostril is at least 100% of the diameter of the prong.
Preferably the nasal prong is curved about a centre of curvature located towards the front of the user's nose so that the prong curves towards the front of the user's nasal passage in use.
Preferably the nasal prong is substantially straight.
Preferably the body comprises a pair of side arms, each side arm in use passing across a user's upper lip region.
Preferably in use a distal end of each side arm rests substantially on the front of a user's face adjacent a side of the user's nose.
Preferably the body is an integrally formed unit comprising the inlet, nasal prongs and side arms.
Preferably a connection is formed in each side arm for connecting the nasal cannula to headgear for holding the nasal cannula in place on a user's head in use.
Preferably the body comprises a bridge portion, in use the bridge portion supporting the cannula on a user's upper lip region, the bridge portion providing a channel between the bridge portion and a rear extent of the nasal prongs, the channel providing a path for exhaled gases to flow.
Preferably the cross section of the channel is adjustable to adjust the distance the nasal prongs are spaced from the area of the body in contact with a user's upper lip region in use.
Preferably the cross section of the channel is adjustable by a screw received in a screw thread.
Preferably the nasal cannula comprises a single nasal prong for insertion into a user's nostril in use, the user's other nostril being vacant, and the body comprising a channel aligned with the vacant nostril for exhaled gases to flow through.
In another aspect, the present invention consists in a nasal cannula for use in a system for providing a flow of respiratory gases to a user, the nasal cannula comprising: a body made from a pliable first material comprising an inlet for receiving a flow of gases and at least one nasal prong for insertion into a user's nostril in use, the at least one nasal prong fluidly connected to the inlet, wherein the body comprises an area for contacting the user's face or nose or both, in use contact between the area and the user's nose or face or both setting the position of the prongs forwardly in the user's nostrils to provide a gap between a rear extend of the nasal prong and the back of the user's nostril, and wherein in use contact between the area and the user's nose or face or both sets the angle of the prongs in the user's nasal passage so that the flow of gases are directed towards a front wall of the user's nasal passage, and a frame made from a second material more rigid than the first material, the frame attached to or integrally formed with the body.
Preferably the at least one nasal prong is fluidly connected to the inlet via a chamber and a wall of the chamber comprising a membrane, the at least one prong extending from the membrane, the radial wall thickness of the at least one prong being greater than the membrane thickness.
Preferably the membrane is annular and surrounds the root of the nasal prong.
Preferably a radial length of the annular membrane is greater than the radial distance from an inner circumferential perimeter to an outer circumferential perimeter, the nasal prong extending from the inner circumferential perimeter.
Preferably a tip of the at least one nasal prong is angled to approximately match the angle of a nasal passage wall.
Preferably each nasal prong has an outlet for the flow of respiratory gases to flow from the cannula, and the nasal prong and outlet are arranged so that the outlet is not visible when the nasal prong is viewed from the rear and along a line parallel to where the bottom of the user's nasal passage would be relative to the prong in use.
Preferably wherein in use the outlet of each nasal prong faces the front wall of the user's nasal passage.
In another aspect, the present invention consists in a nasal interface for use in a system for providing a flow of respiratory gases to a user, the nasal interface comprising: a body made from a pliable first material comprising an inlet for receiving a flow of gases and at least one nasal outlet comprising a tubular structure for interfacing with a user's nostril in use, the at least one nasal outlet fluidly connected to the inlet, wherein at least one plastically deformable member is attached to or integrally formed with the body, the plastically deformable member having an elastic limit substantially less than the elastic limit of the first material.
Preferably a said plastically deformable member is integrally formed with the first material in a wall of a said nasal outlet.
Preferably the body comprises a pair of side arms, each side arm extending from a side of a central portion to in use pass across a user's upper lip region, and a said plastically deformable member is integrally formed with the first material of both side arms to extend across the user's upper lip region in use.
Preferably the at least one plastically deformable member is a metal wire.
Preferably the at least one plastically deformable member is a metal strap.
Preferably the nasal interface is a nasal cannula, the at least one nasal outlet is a nasal prong for insertion into a user's nostril in use.
Preferably the at least one nasal outlet is a nasal pillow for providing a seal against a user's nostril in use.
In another aspect the present invention consists in a restrictor for use in a system for providing a flow of respiratory gases to a user, the system comprising a gases source, a patient interface, a flow path between the gases source and the patient interface comprising at least one conduit, in use the restrictor providing a dominant flow restriction in the flow path such that the flow rate or pressure of the flow of respiratory gases provided by the gases source or received by the user is substantially unaffected when the conduit or patient interface is partially occluded.
Preferably the flow restrictor comprises a gradually reducing cross sectional flow area.
Preferably the restriction comprises a bullet or approximate ogive shaped piece mounted coaxially within a cylinder and supported by spokes extending from an inner surface of the cylinder, the tip of the bullet or approximate ogive shaped piece facing into the flow of gases.
Preferably the spokes extend longitudinally in an axial direction.
Preferably the restrictor is adapted to be retrofitted to an existing system.
Preferably the restrictor is fitted to a patient interface or the conduit.
Preferably the restrictor is integrally formed with a patient interface or the conduit.
In another aspect the present invention consists in a system for providing a flow of respiratory gases to a user comprising a gases source, a patient interface, a flow path between the gases source and the patient interface comprising at least one conduit, and a restrictor positioned in the flow path, the restrictor providing a dominant flow restriction in the flow path such that the flow rate or pressure of the flow of respiratory gases provided by the gases source or received by the user is substantially unaffected when the conduit or patient interface is partially occluded.
Preferably the system comprises a controller for controlling the gases source to provide a gases flow to the flow path, the controller adapted to receive a user settable input, in use the controller controlling the gases source to provide a gases flow to the flow path at a first pressure, and when the controller receives said input the controller controlling the gases source to provide a gases flow to the flow path at a second pressure, the second pressure being higher than the first pressure by an amount approximately equivalent to a pressure drop across the restrictor.
Preferably the system comprises a display for displaying information to a user, the display displaying the first pressure when the controller controls the gases source to provide a gases flow to the flow path at the second pressure.
In another aspect, the present invention consists in a patient interface for use in a system for providing a flow of respiratory gases to a user, the system comprising a gases source and a flow path between the gases source and the patient interface comprising at least one conduit, wherein the patient interface comprises a restrictor, in use the restrictor providing a dominant flow restriction in the flow path such that the flow rate or pressure of the flow of respiratory gases provided by the gases source or received by the user is substantially unaffected when the conduit or patient interface is partially occluded.
In another aspect the present invention consists in a nasal interface for use in a system for providing a flow of respiratory gases to a user, the nasal interface comprising: an inlet for receiving a flow of gases, at least one nasal outlet comprising a tubular structure for interfacing with a user's nostril in use, the at least one nasal outlet fluidly connected to the inlet, and a strap for passing over and contacting a user's nose to support the nasal interface, the strap extending from the nasal interface either side of a central location on the nasal interface.
Preferably the nasal interface comprises a pair of side arms, each side arm extending from a side of the central portion to in use pass across a user's upper lip region, a distal end of each side arm resting substantially on the front of a user's face adjacent a side of the user's nose, and the strap extending from near the distal end of each side arm.
Preferably the strap and nasal interface are integrally formed.
Preferably the distal end of each side arm is provided with a connection for attachment to head gear for holding the nasal interface in place on a user's face in use, the strap extending from each side arm adjacent each connection.
Preferably the connection is a slot for receiving a head gear strap through to attach the head gear to the side arm, the slot being substantially perpendicular to a longitudinal axis of the side arm.
Preferably the nasal interface is a nasal cannula, the at least one nasal outlet is a nasal prong for insertion into a user's nostril in use.
Preferably the at least one nasal outlet is a nasal pillow for providing a seal against a user's nostril in use.
In another aspect, the present invention consists in a nasal interface for use in a system for providing a flow of respiratory gases to a user, the nasal interface comprising: an inlet for receiving a flow of gases, at least one nasal outlet comprising a tubular structure for interfacing with a user's nostril in use, a chamber fluidly connecting the at least one nasal outlet to the inlet, wherein a wall of the chamber comprises a membrane, the at least one outlet extending from the membrane, the radial wall thickness of the at least one outlet being greater than the membrane thickness.
Preferably the membrane is annular and surrounds the root of the nasal outlet.
Preferably a radial length of the annular membrane is greater than the radial distance from an inner circumferential perimeter to an outer circumferential perimeter, the nasal outlet extending from the inner circumferential perimeter.
Preferably the membrane is shaped to be approximately a fraction of a torus, the torus being formed by rotating a closed first curve about a line in its plane but not intersecting it, the fraction of a torus being formed by truncating the torus through a plane approximately perpendicular to said line.
Preferably the membrane is shaped to be approximately a half torus formed by truncating the torus through the centre of the closed first curve.
Preferably the first curve is a circle.
Preferably the wall of the outlet extends from the inner circumferential perimeter of the fraction of a torus and the wall of the chamber extends from an outer circumference of the fraction of torus.
Preferably the wall of the outlet extends from the inner circumferential perimeter of the fraction of torus with the inside of first curve facing a tip of the outlet.
Preferably the first curve is a circle and the wall of the prong extends approximately perpendicularly to a radius of the first curve.
Preferably the first curve is a circle and the wall of the chamber extends approximately parallel to a radius of the first curve.
Preferably the membrane is shaped to be approximately a fraction of a sphere, the fraction of a sphere being formed by truncating a sphere on a first plane and a second plane, the inner circumferential perimeter being on the first plane and the outer circumferential perimeter being on the second plane.
Preferably the second plane is approximately through the centre of the sphere.
Preferably the outlet extends from a convex side of the membrane.
Preferably the nasal interface is a nasal cannula, the at least one nasal outlet is a nasal prong for insertion into a user's nostril in use.
Preferably the at least one nasal outlet is a nasal pillow for providing a seal against a user's nostril in use.
In another aspect the present invention consists in a nasal cannula for use in a system for providing a flow of respiratory gases to a user, the nasal cannula comprising: an inlet for receiving a flow of gases, at least one nasal prong for insertion into a user's nostril in use, the at least one nasal prong fluidly connected to the inlet, wherein an outlet at the tip of the at least one nasal prong is angled to approximately match the angle of a nasal passage wall.
Preferably the outlet at the tip of the at least one nasal prong is angled to approximately match the angle of the nasal passage side wall, the outlet being angled downwards from a centreline of the user's nose when viewed from the front of the user.
Preferably the angle between the nasal passage side wall and the nasal prong tip is less than 30°.
Preferably the at least one nasal prong is angled to match angle of the front of the nasal passage, the tip being angled forwardly.
Preferably the angle between the front of the nasal passage and the nasal prong tip is less than 20°.
In another aspect, the present invention consists in a nasal cannula for use in a system for providing a flow of respiratory gases to a user, the nasal cannula comprising: an inspiratory flow path comprising an inlet for receiving a flow of gases, at least one nasal prong for insertion into a user's nostril in use, the at least one nasal prong fluidly connected to the inlet, wherein a noise suppression material is provided in the inspiratory flow path.
In another aspect, the present invention consists in a nasal cannula for use in a system for providing a flow of respiratory gases to a user, the nasal cannula comprising: an inspiratory flow path comprising an inlet for receiving a flow of gases, at least one nasal prong for insertion into a user's nostril in use, the at least one nasal prong fluidly connected to the inlet, an expiratory flow path, in use expiratory gases flowing from the user's nostril via the expiratory flow path, wherein a noise suppression material is provided in the inspiratory flow path or the expiratory flow path or both.
Preferably the inspiratory flow path comprises a chamber fluidly connecting the inlet to the at least one nasal prong, the noise suppression material located in the chamber.
Preferably the cannula comprises a bridge portion, in use the bridge portion supporting the cannula on a user's upper lip region, the bridge portion providing a channel between the bridge portion and a rear extent of the at least one nasal prong, the channel providing the expiratory flow path.
Preferably the cross section of the channel is adjustable to adjust the distance the nasal prongs are spaced from the area of the face contacting portion in contact with a user's upper lip region in use.
Preferably the cross section of the channel is adjustable by a screw received in a screw thread.
Preferably the nasal cannula comprises a single nasal prong for insertion into a user's nostril in use, the user's other nostril being vacant, and the face contacting portion comprising a channel aligned with the vacant nostril, the channel providing the expiratory gases flow path.
In another aspect, the present invention consists in a nasal interface comprising: an inlet, at least one nasal outlet for interfacing with a nostril of a user, a chamber for fluidly connecting the inlet to the nasal prong, a bridge portion for supporting the cannula on an upper lip region of a user, a space between the bridge portion and the chamber providing an air gap between the chamber and the user's upper lip region.
Preferably the distance between the bridge portion and the chamber is adjustable to adjust the distance the chamber is spaced from the user's upper lip region in use.
Preferably the distance between the bridge portion and the chamber is adjustable by a screw received in a screw thread.
Preferably the nasal interface is a nasal cannula, the at least one nasal outlet is a nasal prong for insertion into a user's nostril in use.
Preferably the at least one nasal outlet is a nasal pillow for providing a seal against a user's nostril in use
The term “comprising” as used in this specification and claims means “consisting at least in part of”. When interpreting each statement in this specification and claims that includes the term “comprising”, features other than that or those prefaced by the term may also be present. Related terms such as “comprise” and “comprises” are to be interpreted in the same manner.
To those skilled in the art to which the invention relates, many changes in construction and widely differing embodiments and applications of the invention will suggest themselves without departing from the scope of the invention as defined in the appended claims. The disclosures and the descriptions herein are purely illustrative and are not intended to be in any sense limiting.
The invention consists in the foregoing and also envisages constructions of which the following gives examples only.
Preferred embodiments of the invention will be described by way of example only and with reference to the drawings.
A preferred form of nasal interface arrangement is described below with reference to use as part of a patient interface for use in a medical gases system. It should be noted that the nasal interface arrangement can be used with any suitable system that provides a gases stream from a gases source to a patient in use. For example, it could be used as part of a system to provide supplementary oxygen to a user, with the oxygen provided from a source such as a gas bottle or wall outlet. However, it is described below by example for use in a system that provides a heated, humidified, gases stream to a patient or user. The nasal interface is suitable for use in the home or in a hospital environment. The nasal interface can be varied in size (with the proportions kept generally the same) for use with users of different sizes. For example, two (or more) different sizes could be produced for adult and infant users, but still fall within the scope of the present invention.
Referring to
In the preferred form as shown in
It should be noted that the system used with the nasal interface does not require the use of a humidifier—that is, the gases stream could be dry and unheated if required. Various types of therapy can be delivered by using the nasal interface. The preferred form of therapy will be described later. Generally any gases and respiratory gases delivery system can be used with the nasal interface. The respiratory humidification described here is just an example of the type of therapy and system the nasal interface can be used with or as part of.
The controller 9 receives inputs from sources such as user input via dial 10, through which a user of the device may, for example, set a predetermined required value of humidity or temperature of gases supplied to the patient 1. In response to the user input or input from any other possible inputs like sensors (for example temperature or humidity sensors, not shown), the controller 9 determines when to and what level to energise the heater plate 7 to heat the water 6 within the humidification chamber 5. As the volume of the water 6 within the humidification chamber 5 is heated, water vapour begins to fill the remaining volume of the humidification chamber 5. The gases which are provided to the humidifier unit 2 from the gas source unit 15 enter the humidification chamber 5 above the surface of the water 6, and are humidified by the water vapour within the humidification chamber as they pass through the chamber 5. The heated humidified gases exit the humidification chamber 5 through an outlet 4 and are transferred to the patient interface 20 by the delivery conduit 3.
By example, the gas source unit is a blower unit. The preferred form of blower 15 is provided with a variable speed pump or fan 12 which draws air or other gases through a blower inlet 17. The speed of the pump or fan 12 is in the preferred embodiment controlled by a further control apparatus 18. Alternatively control of the pump or fan speed can be carried out by controller 9. The fan controller 18 can also be adapted to receive inputs from sensors in the system, or a user input from a control panel or control unit 19. As noted above, the blower unit 15 can be supplemented by or replaced by a gases source such as a gases bottle or a wall-mounted outlet connected to a central gases source. Alternatively the blower unit and humidifier unit may be packaged into a single integrated blower and humidification unit.
The preferred system also comprises a user display 13 for communicating information to a user such as operating mode selection and operating parameters such as actual pressure or flow provided by the blower, temperature of gases flow, humidity of gases flow, compliance hours of use and other information useful to a user.
The preferred form of delivery conduit 3 includes a heating element 11 to prevent condensation of humidified gases occurring within the conduit 3 (‘rain out’).
The preferred form of humidification system has been described above, with the nasal interface described as being included as part of the patient interface 20. Various inventions relating to nasal interfaces are described below with reference to nasal cannulae. However, one or more inventions described and claimed below may be useful in nasal interfaces comprising nasal outlets with pillows for providing a seal at the user's nostrils. Inventions are described with reference to nasal cannulae by way of example only. An alternative patient interface 200 including nasal outlets with pillows 620 according to one or more present inventions is shown in
Patient Interface
Head Securement
In the preferred embodiment, the patient interface 20 is secured to the patient's head or face by a strap 50, as shown in
The most preferred form of head strap device is adjustable to allow patients of different sizes and head shapes to use the nasal cannula 30. For example, an adjustment buckle could be included which allows a patient to loosen or tighten the head strap 50.
Preferably the strap 50 comprises two separate straps 50a and 50b. As shown in
As best shown in
The buckle 54 is particularly flat and small so that the user does not feel the buckle in use, even when the weight of the user's head rests on the buckle where the buckle is positioned between the user's head and the user's bedding.
The head securement mechanism may further comprise a loop 56 that passes over the user's nose in use, as shown in
The cannula illustrated in
The headgear of
Gases Inlet Conduit
The secondary supply conduit 45 will now be described in detail. The secondary supply conduit 45 is a short length of conduit or tubing which runs between the outlet of the main delivery conduit 3 and the nasal cannula 30. In use, gases exit the main delivery conduit 3 and enter the secondary supply conduit 45, to flow along the secondary supply conduit 45 to the patient. One reason that a secondary conduit is used is as follows: the main delivery conduit 3 is relatively heavy and cumbersome as it is used to transport gases over a reasonably long distance (from the humidifier unit 2 to a point close to the patient). The main delivery conduit 3 is therefore required to have a wall that is strong enough to support its own weight without collapsing. As the main delivery conduit 3 is therefore relatively long (e.g. 2 to 3 meters), this additional length and the thicker wall structure adds to the weight of the main delivery conduit 3. If the outlet of the main delivery conduit 3 is connected directly to the patient interface in such a manner that the user 2 is required to support this weight, this can cause discomfort to the user due to the weight of main delivery conduit acting on the user. A lighter, shorter secondary conduit (e.g. secondary supply conduit 45) is therefore frequently used, running between the outlet of the main delivery conduit 3 and the patient interface 20. Secondary supply conduit 45 is lighter and shorter than the main delivery conduit 3.
In order to reduce condensate forming in the unheated secondary supply conduit 45, a conduit that has vapour transmission properties can be provided. The secondary supply conduit 45 can be integrally formed with the main delivery conduit 3 or may be attached by some connection mechanism, allowing for detachment of the secondary supply conduit 45 from the main delivery conduit 3. The connection mechanism can be a threaded screw type connector or a friction locking mechanism. The secondary supply conduit is preferably made from a hydrophilic material, for example SYMPATEX.
The secondary conduit may, for example, be approximately 300 mm long. The result of providing a short secondary supply conduit 45 is that a majority of humidity in the gases is transported to the patient, and there is an insignificant and immeasurable loss of humidity through the breathable wall of the short secondary supply conduit, while condensate forming is reduced.
The secondary conduit 45 preferably has a smaller diameter than the conduit 3. For example, the secondary conduit may have an internal diameter of approximately 11 mm and the conduit 3 may have an inner diameter of approximately 16 mm.
The nasal cannula and its various features will now be described in more detail.
Nasal Cannula
The preferred form of the nasal cannula 30 that forms part of the patient interface 20 shall now be described in more detail with particular reference to
The preferred cannula assembly comprises two main parts, a resilient, flexible, pliable cannula body and a clip or frame that provides support or structural strength to the cannula assembly. Preferably the body contacts the user's face in use, for example an upper lip region of the user's face.
The cannula body 60 comprises a manifold 61 and a nasal prong or nasal prongs 62. Each nasal prong extends into a user's nostril in use. The manifold has an inlet or aperture 63 for receiving a conduit. Preferably the aperture is sized to receive a secondary conduit as described above. Alternatively the inlet may be adapted to receive the conduit 3. However this is less preferred. The aperture or inlet is fluidly connected to a nasal prong or pair of nasal prongs. In use, a respiratory gases flow provided to the cannula assembly via the conduit connected to the cannula assembly enters the cannula assembly via the inlet, passes through the manifold to exit each prong to enter the user's nostrils.
The nasal prongs do not seal to the nostrils of the user. Where the user exhales via his or her nostrils, exhaled gases pass out of the nostrils via clearance between the inner wall of the nostrils and the outside of the nasal cannula prongs.
A conduit for connection to the cannula comprises a connector 40 for attachment to the nasal cannula assembly. Preferably connector and matching aperture are circular. However, other shapes may be substituted, for example an oval shape. The connector 40 is fitted to an end of the conduit and may be considered to be a part of the conduit or an end of the conduit. For example an outer diameter of the connector may be received in an internal diameter of the conduit. The connector may be bonded or moulded to the conduit.
The connector 40 comprises a groove or a circumference 41 located between a first lip or surface 42 extending radially from the connector and a second lip or surface 43 extending radially from the connector. Groove 41 is annular and extends around the circumference of connector 40. Preferably the first lip and second lip extend fully around the circumference of the connector. Alternatively, the first and second lip 42, 43 may extend for a portion of the circumference of the connector 40.
The manifold 61 further comprises an internal groove 64 extending around the perimeter of the aperture. In use the first lip 42 is received in the manifold groove 64, fluidly connecting the conduit to the manifold of the cannula body.
In the preferred embodiment of the nasal cannula, the manifold inlet is oriented to face downwards when a user is wearing the nasal cannula in a standing position. With the conduit connected to the cannula body, the conduit can hang downwards from the cannula. With the user in a standing position, the nasal pongs extend upwards from a top surface of the cannula body.
As the cannula body is made from a resilient, flexible, pliable material, the aperture is easily stretched over the first lip 42 of the conduit connector so that the lip 42 seats within the groove. The fit between the groove and the lip 42 is preferably a tight fit. However, because the body is a flexible and made from a resilient and pliable material, the conduit connector can be twisted relative to the cannula body.
The cannula body preferably further comprises side arms 65. Each side arm extends from a side of a central portion of the cannula body and in use passes across a user's upper lip region to terminate adjacent a corresponding cheek region. Preferably each side arm is angled slightly backwards from the central portion towards the face of the user in use, and angled upwards so that the side arms each extend from the central portion on a line that passes near the top of each ear. In use the ends of the side arms distal from the central portion rest substantially on the front of a user's face adjacent a side of the user's nose where the user's upper lip region terminates.
Preferably the cannula body 60 comprising the side arms, manifold and nasal prongs is an integrally formed flexible, resilient, pliable unit. Preferably the cannula body is made from silicone with a Shore A hardness of between 10 and 60. However, any other suitable pliable material with similar properties may be used.
In use head gear (described above) is coupled adjacent to the distal ends of each side arm to hold the nasal cannula assembly in place on a user's face. With appropriate connections provided to each side arm, in use the nasal cannula 30 may comprise only the integrally formed cannula body, attached to the conduit 3 or 45 and the head gear. However, the preferred cannula embodiment is an assembly further comprising the frame or clip 31.
The frame 31 provides support to the cannula assembly 30 and helps to secure the conduit connector 40 to the cannula 30. Without the frame, the connector 40 is retained within the aperture of the cannula body by first lip 42 of connector 40 residing within the groove in the resilient and pliable material of the cannula body only. In this case, only a relatively small axial force is required to pull the connector away from the manifold, to deform the pliable aperture over the first lip 42 of connector 40.
The frame is formed from a relatively stiff material; a material that has a higher stiffness compared to the resilient, flexible or pliable cannula body. For example, the frame is formed from a suitable rigid or semi-rigid material such as a polycarbonate plastic, a polypropylene plastic or other suitable material. The pliable cannula body can be deformed easily, for example a portion of the cannula body can be bent to be doubled over on itself without noticeable plastic deformation. In contrast, the rigid or semi rigid frame is capable of elastic deflection, but the frame has a significantly higher Youngs Modulus compared to the cannula body. A portion of the frame cannot be bent over on itself without plastic deformation. The cannula body material is softer than the frame material.
The frame 31 comprises an at least one first projection and an at least one second projection. The first projection engages to the conduit connector. As best shown in
In the preferred embodiment the flange 34 is substantially perpendicular to the axis of conduit connector 40. The flange 34 comprises a hole 35 for clasping about the groove of connector 40. The hole 35 is circular and is open on one side for receiving connector 40. The internal diameter of hole 35 matches the external diameter of groove 41 such that a loose fit is achieved between the groove 41 and hole 35 when connector 40 is received in hole 35. The width of the opening in the side of the hole is less than the diameter of the groove 41. To attach frame 31 to connector 40, connector 40 is pushed via the opening into hole 35. The frame is elastically deformed to spread the opening wide enough to receive the groove of connector 40 during attachment of the connector to frame 31. Once the connector is located within the hole, with the centres of the hole and connector substantially aligned, the frame returns to its undeformed state, radially capturing the connector groove within hole 35. The first and second lip 42 and 43 of connector 40 rest either side of flange 34 to retain the connector within the flange of frame 31 in a direction along the axis of the connector. The matched diameters of the hole 35 and the groove 41 allow the connector to swivel or rotate about the axis of the conduit. The conduit may be detached from the frame by spreading the opening of hole 35 to allow the groove to pass via the opening.
As described previously, the aperture of the cannula body is fitted over the first lip 42 of the connector 40. Thus the cannula body is radially captured on the connector 40.
To securely retain the cannula body on the connector 40 in an axial direction, the frame comprises the at least one second projection. The second projection engages to the face contacting portion. Without the second projection, the cannula body could be pulled axially away from the connector 40 relatively easily. In the assembled cannula assembly, the second projection 33 is received in a corresponding recess 67 in the cannula body, as best shown in
The second projection is preferably a second flange that is received in a corresponding recess in the cannula body. Preferably the second flange extends substantially perpendicular to the axis of the connector 40. With the second projection received in the recess, the cannula body is securely retained in an axial direction.
Alternatively, the second projection may be a peg to be fitted into a corresponding hole in the cannula body, or any other projection to be received in a corresponding recess.
To assemble the cannula assembly together, in a first step the cannula body 60 is attached to connector 40 of conduit 3 or 45, by stretching the rim 66 of the inlet aperture of the manifold over the first lip 42 of connector 40. In a second step, the frame is pushed in a direction substantially perpendicular to the axis of connector 40, to capture the first projection or flange 34 of frame around the groove 41 of connector 40, while simultaneously engaging the second projection 33 of frame 31 with recess 67. To disassemble the cannula assembly the first and second steps are reversed.
Alternatively, the cannula body and frame may be assembled together in a first step. In a second step the connector may be attached to the frame and cannula body by pushing the connector into the hole in a direction along the axis of the conduit. For example, as shown in
Alternatively, the frame may be attached to the connector 40 in a first step. In a second step, the cannula body is pushed axially onto the first lip of connector 40 and the second projection of frame is eased into the recess in the cannula body. However this assembly method is the least preferred.
The frame may comprise a plurality of first projections and a plurality of second projections. For example, in alternative embodiment of
In the preferred embodiment the frame 31 further comprises side arms 32. The frame side arms, first projection and second projection are preferably integrally formed. Each side arm extends from a central portion and in use passes across a user's upper lip region to terminate adjacent a corresponding cheek region. Preferably each side arm is angled slightly backwards from the central portion towards the face of the user in use, and angled upwards from the central portion so that the side arms each extend on a line that passes near the top of each ear. In use the ends of the side arms distal from the central portion locate substantially at the front of a user's face adjacent a side of the user's nose where the user's upper lip region terminates.
In the preferred embodiment, in use, the cannula body side arms 65 rest in between a user's face and the frame side arms 32. As described above, the material of the cannula body is softer than the frame material. The cannula body provides a cushion between the frame 31 and the user's face.
The distal end of each frame side arm 32 is provided with a connection for attachment to the head gear for holding the cannula in place on a user's face. Preferably each frame side arm includes a slot 36 for passing a strap 50 of the head gear through, to attach the head gear to the frame. Preferably the slot is substantially perpendicular to a longitudinal axis of the side arm, so that a longitudinal axis of the strap extends approximately in line with the longitudinal axis of the frame side arm. Alternatively the head gear may be attached to the cannula via a quick release connector provided with one or both side arms for quickly disconnecting the head gear from at least one side of the cannula 30.
In the preferred cannula assembly, each cannula body side arm 65 comprises a retainer for attaching the cannula body side arm to the corresponding frame side arm. For example, the cannula body side arm may include a peg extending from a surface of the side arm facing the frame. The peg is received in a corresponding hole in the frame side arm. Interference between the peg and the corresponding hole retains the cannula body side arm in proximity with the corresponding frame side arm.
In the preferred cannula assembly as shown in
Alternatively, frame 31 may not have side arms. In this case the headgear strap is attached to the cannula body side arms.
In a further alternative embodiment, frame 31 may not be removable or separable from the cannula body 60. For example, the frame may be integrally moulded with the cannula body.
The cannula may include one or more titration ports to allow a sensor to communicate with the flow of gases at the cannula. For example, as shown in
Cannula Nasal Prong Orientation
Prior art nasal cannula assemblies include nasal prongs that are angled or curved backwards into the user's head to match the angle of the user's nasal passages. Such an arrangement has been considered beneficial in order to provide a comfortable fit. To receive the nasal prong comfortably in the nasal passage the nasal prong is shaped to follow the nasal passage. An example of this arrangement is shown in
However, the inventors have found the surprising result that an improvement in user comfort can be achieved with nasal prongs that are aligned towards the front of the user's nasal passage within the user's nose. The benefit of such an arrangement is a reduction in noise during use. A reduction in noise results from a reduction in flow collision between inspiratory and expiratory respiratory gases. Inspiratory gases are directed up the front of the nasal passage within the user's nose, as indicated by arrow A in
Preferably in use the cannula is arranged so that a longitudinal axis of each nasal prong at the tip of each nasal prong is parallel to or angled forward of a plane, the plane being vertical when the user is in a standing position with the user's head held level.
Preferably, in use each nasal prong is arranged to direct the flow of gases towards the front wall of the user's nasal passage within the user's nose.
Preferably, in use each nasal prong is arranged to direct the flow of gases towards the front wall of the user's nasal passage within the user's nose adjacent the user's nostril.
The inventors also believe a reduction in noise is achieved by reducing the amount exhalation gases flow onto the outlet of each nasal prong. Each nasal prong provides an outlet for the respiratory gases to exit the nasal prong and enter the user's nasal passage. In the preferred cannula the outlet of each nasal prong is angled so that a plane of the outlet is parallel to or angled away from the flow path of the exhalation gases. It is thought by the inventors that the exhalation gases flow from the rear of the user's nasal passages generally along the bottom of the nasal cavity. With the user in a standing position and with his or her head held level, the bottom of the nasal passage is approximately horizontal, and the exhalation gases flow generally horizontally along the bottom of the nasal passage. With the user in this position, it is preferable that the outlet is angled so that a plane of the outlet is horizontal to the bottom wall of the nasal passage or angled forwardly towards the front wall of the nasal passage. Alternatively, the preferred angle of the nasal prong outlet may be described as follows. The nasal prong outlet is angled so that the general plane of the nasal prong outlet is approximately parallel to the bottom of the user's nasal passage or angled forwardly towards the front wall of the user's nasal passage in use. Yet another way of describing the preferred angle of the nasal prong outlet is that the outlet is angled so that it is not visible when the prong is viewed from the rear and along a line parallel to where the bottom of the nasal passage would relative to the nasal prong in use.
The outlet may be formed as a planar outlet across the nasal prong perpendicular to the longitudinal axis of the prong at the tip of the prong. In this case, the correct angle of the outlet is achieved by a nasal prong angled so that the longitudinal axis of the prong at the tip of the prong is perpendicular to the bottom wall of the nasal passage or angled forwardly towards the front wall of the nasal passage. In this arrangement, the nasal prong outlet is not visible when the prong is viewed from the rear and along a line of the bottom of the nasal passage.
In other arrangements the nasal prong outlet maybe angled relative to the longitudinal axis of the prong. In this form the prong may extend rearwards in the user's nasal passage to generally follow the nasal passage. In this case the outlet of the prong would be formed at an angle sufficiently far from perpendicular to the axis of the prong, so that the outlet is angled to be parallel to the bottom wall of the nasal passage or face the front wall of the nasal passage. Again the outlet is angled so that the outlet is not visible when the prong is viewed from the rear and along a line of the bottom of the nasal passage. A person skilled in the art will understand there are many different combinations of prong angle and corresponding outlet angle that can be used to achieve an outlet that is parallel to the bottom surface of the nasal passage or angled forwardly towards the front wall of the nasal passage.
To facilitate the correct orientation of the nasal prong or nasal prong outlet in the nasal passage, the cannula has a face contacting area 70 (
With the face contacting area sitting flat against the user's upper lip region, the angle of the prong is set correctly to ensure inspiratory air is directed towards the front of the nasal passage. Preferably the nasal prong is curved with a centre of curvature towards the front of the user's nose so that the prong curves towards the front of the nasal passage. The curve of the nasal prong may not be circular, for example, there may be more than one centre of curvature about which the prong is curved. Alternatively the nasal prong is straight. For example the prong may be straight with a longitudinal axis parallel to or angled forward relative to the plane of a cannula body in contact with the users upper lip region.
In one embodiment, the longitudinal axis of the prong at the tip of the prong is preferably angled at least 10° forward of the plane of the area contact with the user's upper lip region.
An area of the cannula may contact other areas of the user's face. For example the cannula may rest on the cheeks of the user, this contact with the user's cheeks setting the angle of the prongs in the user's nasal passages correctly. In an alternative but preferred embodiment, the cannula contacts the junction between the user's upper lip region and the user's septum, in use the head gear pulls the cannula against this junction to position the nasal prongs correctly.
With the face contacting area sitting flat against the user's upper lip region or other region of the user's face or nose, the prong is spaced correctly towards the front of the nostril, creating a gap at the rear of the nasal passage for the expiratory gases to exit the nostril. In the illustrated embodiment of
The part of the cannula in contact with the user's face or nose is preferably made from a pliable, flexible, resilient material. However, the cannula preferably does not easily collapse in the region between the users face or nose (e.g. the upper lip area) and the rear extent of the nasal prong. This may be achieved by having a solid cross section between the rear extent of the nasal prong and the area of the cannula in contact with the user's face or nose. For example, the hollow manifold of the cannula body does not extend significantly rearward of the rear extent of the nasal prong.
In a further embodiment, the nasal cannula may include an expiratory flow path between the manifold and an area of the cannula body in contact with the user's upper lip region. As shown in
The bridge portion 73 may be integrally formed with the cannula body, for example from a pliable, resilient, flexible material. The bridge portion may act substantially as a leaf spring that bends about the connection points 74 that connect the bridge portion 73 to the remainder of the cannula body 31 of the cannula 30. Preferably the bridge portion and connection points 74 provide enough resiliency to ensure the channel does not close up with the bridge portion collapsing towards the manifold due to tension provided by the head gear straps. Satisfactory resiliency can be achieved by choosing a suitable cross section for the channel.
In a further embodiment, the cross section of the channel may be adjustable to suit a particular user. For example, as shown in
Another benefit of the bridge portion is the manifold is spaced from the user's upper lip. When providing heated gases to a user, heat from the gases can be transferred via conduction through the cannula material to the user's upper lip region. This heat can cause the user's upper lip region to perspire which can be uncomfortable for the user. The bridge portion helps to insulate the user's upper lip region from the warm gases by providing an air gap between the manifold and the lip region.
An alternative embodiment nasal cannula comprises a single nasal prong only. An example is illustrated in
A noise suppression media may be utilised to suppress noise created by the inspiratory gases or expiratory gases in the nasal passages or cannula, or noise transmitted through the pathway from the gases source unit. For example, as shown in
In a further alternative embodiment, a conduit providing a flow of gases to the cannula may communicate with a nasal prong or prongs via a connection in a side arm. For example, as shown in
Alternatively a conduit may be provided to one side of the nasal cannula only, connecting with a side arm lumen that communicates with both a left and right nasal prong. The side arm may comprise a single lumen communicating with both nasal prongs. Alternatively the side arm may comprise a multi-lumen. For example the side arm may comprise a double lumen, one lumen per nasal prong, as shown in
Flow Restrictor
Another invention described herein relates to a flow restrictor incorporated in the air flow path between the gas source unit 15 and the patient. The flow restrictor may be incorporated into any suitable medical gases system that provides a gases stream from a gases source to a patient in use. However, it is described below by example for use in a system that provides a heated, humidified, gases stream to a patient or user.
The flow restrictor may be located in the air flow path at any position between the gas source unit and the patient. For example, the air flow restrictor may be located at an outlet end of the conduit 3, an inlet end of the secondary conduit 45, an outlet end of the secondary conduit 45, or a patient interface, for example a nasal interface comprising the nasal cannula assembly 30, or any other patient interface such as a nasal mask or a full face mask. By example only, the air flow restrictor 80 is shown in
In use, a patient using a gases supply system may restrict the gases flow by inadvertently squashing the conduit 3. For example, a patient may roll onto the conduit 3 during sleep, the patient's body squashing the cross section of the conduit thereby restricting the flow of gases provided to the patient. This situation is undesirable.
The air flow restrictor is provided to be a dominant flow restriction in the air flow system. The air flow restrictor will be the dominant flow restriction even when a portion of the conduit 3 is squashed or pinched. Typical conduits for use in medical gases systems are flexible in an axial direction, but are relatively stiff radially to prevent complete occlusion should the conduit be squashed or pinched by a user. With the cross section partially occluded, the flow restrictor remains the dominant flow restriction in the system. Therefore, even with the conduit 3 partially occluded, the flow received by the patient is not affected. Also, any variation in resistance to flow downstream of the flow restrictor does not affect the operation of the gases source unit, as the dominant flow restriction provided by restrictor 80 acts to decouple the system downstream of the flow restrictor from the system upstream of the flow restrictor. For example the effect on the gases source unit of the partial occlusion of a nasal prong or prongs is mitigated by the flow restrictor. In this case, it may be beneficial to locate the flow restrictor at an outlet of the gases source unit.
With the inclusion of the flow restrictor, to achieve a desired gases flow rate or pressure provided to a patient, the air pressure provided by the gases source unit is increased compared to the same or similar system without the flow restrictor. The increased gases source unit pressure overcomes the pressure drop across the flow restrictor to result in the desired flow or pressure at the patient. With partial occlusion of the conduit 3, the flow or pressure at the patient is not substantially affected.
The air flow restrictor may be a simple orifice plate or any other suitable localized restriction in the system. For example, the restrictor may comprise a small diameter cylinder mounted in-line between the cannula and conduit 3, the air flow passing through and being restricted by the small diameter cylinder. Alternatively and by example only, the restriction could be a cylinder with a disc located coaxially within the cylinder, the disc supported by a spoke or spokes extending from an internal surface of the cylinder. In the preferred embodiment, the flow restrictor comprises a gradually reducing cross section. Air flow passing through a sudden restriction such as an orifice in a plate can create significant noise which is undesirable. Air passing through a gradually reducing cross section is quieter by comparison. For example, as shown in
Alternatively the restrictor is trumpet shaped, the cross section of the restrictor being circular and decreasing in an axial direction along the restrictor in the direction of the flow.
Preferably the spokes of the restrictor of
By example, the preferred embodiment comprises a cylinder with an internal diameter of approximately 10 mm, and a bullet shaped member of approximately 7.5 mm outside diameter. This restrictor is suitable for use with a 30 cm long secondary tube having an internal diameter of 10 mm and a 1.5 m-1.8 m long conduit having an internal diameter of approximately 11 mm.
Without the flow restrictor placed in the system, the gases source unit or blower is set to provide gases at a pressure equal to the pressure expected at the patient interface. When the flow restrictor is placed in the system, the blower pressure is offset by a predetermined amount above the pressure expected at the patient interface to account for the pressure drop across the restrictor.
The preferred system includes a selectable function for indicating to the system controller 18 that the flow restrictor is incorporated into the system. For example, controller 18 is configured to receive an input selectable by a user, for example by a push button on the blower unit. Where the restrictor is used, the user sets the input to indicate to the controller the flow restrictor is in place. In response to receiving the input, the controller automatically adds an offset to the pressure provided by the blower unit. The blower unit display 13 does not display the actual pressure provided by the blower, but displays the pressure expected downstream of the restrictor.
The restrictor may be a standalone item that may be retrofitted to an existing system. For example, the restrictor may be fitted to an inlet of a patient interface such as the cannula assembly 30, or to either end of the secondary conduit or the outlet end of conduit 3. For example, an inlet end of the restrictor comprises an external diameter 84 matched to interface with an internal diameter of the outlet of the conduit 3. An outlet end of the restrictor comprises an internal diameter 85 matched to interface with an internal diameter of the inlet of the secondary conduit 45. Alternatively, the restrictor may be integrally formed with any one of the conduit 3, secondary conduit 45 or a patient interface. The restrictor may be integrally formed with or attached to any type of patient interface, for example a nasal cannula, face mask, nasal mask or any other patient interface known in the art.
Plastic Deformable Inserts for Holding Cannula Shape
The cannula body described earlier may further comprise at least one plastically deformable member. For example, the cannula body may be integrally formed with a metal wire 90 as indicated in
Once plastically deformed the metal wire holds its deformed shape. Therefore the inclusion of the metal wire gives the resilient, flexible, pliable cannula body a shape memory allowing the cannula body to hold its shape once bent, twisted or otherwise formed to match a user's facial profile.
For example, the cannula body may include one or more wires 91 formed in the wall of each nasal prong. In use a patient or other person may manipulate the orientation of each prong to fit the nasal prongs to the patient's nasal passages in a comfortable way. Once manipulated to the desired orientation, the wire will retain the position of the prongs. The cannula body may comprise a wire or other plastically deformable member that extend across the users upper lip region, from one corner of the mouth to the other corner of the mouth. This plastically deformable member can be bent or otherwise manipulated to match the curve of the users upper lip region. The plastically deformable member may be a wire or strap 92 of material or other shape suitable for integrating with the cannula body. The plastically deformable material is preferably a metal with a low elastic to plastic limit. For example the plastic deformable member may be copper, aluminium or other ductile material.
Rolling Diaphragm
Patient interfaces such as cannula assemblies, nasal masks and full face masks are designed to fit a range of different users. However a small number of users may fall outside the typical design range. For such a user, a particular patient interface may not provide an optimal fit. For example, during use a nasal prong may touch or press against a wall of the user's nasal passage. This may cause discomfort over an extended period of use and can result in user non-compliance with a prescribed treatment regime. A very thin walled nasal prong may be utilised so that little pressure against the wall of the nasal passage results should there be contact between the nasal passage wall and nasal prong. However, should a thin walled nasal prong press against the wall of the nasal passage, the cross sectional area of the prong can be partially occluded easily. This causes an increase in air flow which can also cause discomfort and also result in excessive noise.
To help alleviate one or more of the aforementioned problems, an improved nasal cannula comprises a thin section of material between the root of the nasal prong and the surface from which the prong extends. The thin section has a thickness less than the thickness of the wall of the nasal prong. The improvement comprises a cannula with a manifold having a thin membrane in a wall of the manifold and a nasal prong extending from the thin membrane. The thin membrane has a thickness less than the thickness of the wall of the nasal prong. For example as shown in
The thin membrane provides a weak point at or near the root of the nasal prong. When a lateral force is provided to a side of the nasal prong, for example at a tip of the nasal prong, the nasal prong is deflected laterally by bending at the root of the nasal prong. The cross sectional area of the nasal prong is not significantly affected, as the thickness of the prong wall provides sufficient strength compared to the thin membrane such that the prong retains its shape. Therefore the flow rate of gases exiting the nasal prong remains substantially the same, while pressure against the wall of the nasal passage is minimal.
Preferably the thin membrane 111 is an annulus around the root of the prong, the prong extending from the annulus. With reference to
The wall of the prong extends from the inner circumferential perimeter 112 of the fraction of torus and the wall of the manifold extends from the outer circumferential perimeter 113 of the fraction of torus. Preferably the wall of the prong extends from the inner circumferential perimeter with the inside of the first curve facing the tip of the prong. Preferably the first curve is a circle and the wall of the prong extends approximately perpendicularly to a radius of the first curve. Preferably the first curve is a circle and the wall of the manifold extends approximately parallel to a radius of the first curve.
Alternatively, the thin membrane 111 may be approximately a fraction of a sphere formed by truncating a sphere on a first plane and a second plane, the inner circumferential perimeter being on the first plane and the outer circumferential perimeter being on the second plane. For example, the thin membrane is approximately hemispherical as shown in
With the radial length of the thin membrane 111 being longer than the radial distance from the inner circumferential perimeter 112 to the outer circumferential perimeter 113, the thin membrane acts as a diaphragm, and allows the root of the nasal prong to roll or pivot. This allows the prong to move laterally with respect to the longitudinal axis of the nasal prong. The flexibility of movement provided by the thin membrane allows a thicker walled nasal prong to be utilised without reducing comfort of fit in the user's nasal passage. The thicker walled nasal prong retains its cross sectional shape when a sideways or lateral force is exerted to the prong, for example by a contacting nasal passage side wall.
Truncated Tips
As discussed previously, the preferred cannula comprises nasal prongs that are biased or arranged towards the front of the nasal passage. The length of the nasal prongs is selected by the cannula designer to ensure the tip of the prong does not contact the wall of the nasal passage. Contact with the nasal passage may cause discomfort to the user. Ideally the length of the prong is sufficiently long enough to direct the flow of gases in a desired direction. For example, the length of the prong is sufficiently long enough to direct the flow of gases towards the front of the nasal passage, to reduce the amount of flow collision with expiratory gases as explained earlier. Therefore it is desirable to have nasal prongs with sufficient length to direct the flow of gases in a desired direction, while avoiding contact with the wall of the nasal passage.
In the preferred cannula, to assist with directing the flow of gases while avoiding contact with the wall of the nasal passage, the tip of each nasal prong is truncated to match the angle of the nasal passage side walls. As shown in
The foregoing description of the invention includes preferred forms thereof. Modifications may be made thereto without departing from the scope of the invention as defined by the accompanying claims.
| Number | Name | Date | Kind |
|---|---|---|---|
| 301111 | Genese | Jul 1884 | A |
| 472238 | Van Orden | Apr 1892 | A |
| 577926 | Miller | Mar 1897 | A |
| 718470 | Jones | Jan 1903 | A |
| 751091 | Moran | Feb 1904 | A |
| 770013 | Linn | Sep 1904 | A |
| 1635545 | Drager | Jul 1927 | A |
| 2126755 | Dreyfus | Aug 1938 | A |
| 2353643 | Bulbulian | Aug 1938 | A |
| 2228218 | Schwartz | Jan 1941 | A |
| 2241535 | Boothby et al. | May 1941 | A |
| 2296150 | Dockson et al. | Sep 1942 | A |
| 2359506 | Battley et al. | Oct 1944 | A |
| 2388604 | Eisenbud | Nov 1945 | A |
| 2452845 | Fisher | Nov 1948 | A |
| 2508050 | Valente | May 1950 | A |
| 2693800 | Caldwell | Nov 1954 | A |
| 2738788 | Matheson et al. | Mar 1956 | A |
| 2843121 | Hudson | Jul 1958 | A |
| 2859748 | Hudson | Nov 1958 | A |
| 2875759 | Galleher | Mar 1959 | A |
| 2939458 | Lundquist | Jun 1960 | A |
| 3424633 | Corrigall et al. | Jan 1969 | A |
| 3490452 | Greenfield | Jan 1970 | A |
| 3599635 | Kenneth | Aug 1971 | A |
| 3682171 | Dali et al. | Aug 1972 | A |
| 3834682 | McPhee | Sep 1974 | A |
| 3850171 | Ball et al. | Nov 1974 | A |
| 3894562 | Moseley et al. | Jul 1975 | A |
| 3972321 | Proctor | Aug 1976 | A |
| 3977432 | Vidal | Aug 1976 | A |
| 3992720 | Nicolinas | Nov 1976 | A |
| 4090510 | Segersten | May 1978 | A |
| D250047 | Lewis et al. | Oct 1978 | S |
| D250131 | Lewis et al. | Oct 1978 | S |
| 4127130 | Naysmith | Nov 1978 | A |
| 4150464 | Tracy | Apr 1979 | A |
| D252322 | Johnson | Jul 1979 | S |
| 4201205 | Bartholomew | May 1980 | A |
| 4258710 | Reber | Mar 1981 | A |
| 4266540 | Panzik et al. | May 1981 | A |
| 4278082 | Blackmer | Jul 1981 | A |
| 4354488 | Bartos | Oct 1982 | A |
| 4367735 | Dali | Jan 1983 | A |
| 4378011 | Warncke et al. | Mar 1983 | A |
| 4437462 | Piljay | Mar 1984 | A |
| 4454880 | Muto et al. | Jun 1984 | A |
| 4603602 | Montesi | Aug 1986 | A |
| 4621632 | Bartels et al. | Nov 1986 | A |
| 4644974 | Zingg | Feb 1987 | A |
| 4676241 | Webb et al. | Jun 1987 | A |
| D293613 | Wingler | Jan 1988 | S |
| 4753233 | Grimes | Jun 1988 | A |
| 4782832 | Trimble et al. | Nov 1988 | A |
| 4836200 | Clark et al. | Jun 1989 | A |
| 4856508 | Tayebi | Aug 1989 | A |
| 4907584 | McGinnis | Mar 1990 | A |
| 4915104 | Marcy | Apr 1990 | A |
| 4915105 | Lee | Apr 1990 | A |
| 4919128 | Kopala et al. | Apr 1990 | A |
| 4938209 | Fry | Jul 1990 | A |
| 4941467 | Takata | Jul 1990 | A |
| 4944310 | Sullivan | Jul 1990 | A |
| D310431 | Bellm | Sep 1990 | S |
| 4958658 | Zajac | Sep 1990 | A |
| 4971051 | Toffolon | Nov 1990 | A |
| 4986269 | Hakkinen | Jan 1991 | A |
| 5010925 | Atkinson et al. | Apr 1991 | A |
| 5016625 | Hsu et al. | May 1991 | A |
| 5031261 | Fenner | Jul 1991 | A |
| 5042478 | Kopala et al. | Aug 1991 | A |
| D320677 | Kumagai et al. | Oct 1991 | S |
| D321419 | Wallace | Nov 1991 | S |
| 5062421 | Burns et al. | Nov 1991 | A |
| 5065756 | Rapoport | Nov 1991 | A |
| D322318 | Sullivan et al. | Dec 1991 | S |
| 5074297 | Venegas | Dec 1991 | A |
| 5094236 | Amad | Mar 1992 | A |
| 5113857 | Dickerman et al. | May 1992 | A |
| 5121745 | Israel et al. | Jun 1992 | A |
| 5148802 | Sanders et al. | Sep 1992 | A |
| 5164652 | Johnson et al. | Nov 1992 | A |
| 5231979 | Rose et al. | Aug 1993 | A |
| 5243971 | Sullivan et al. | Sep 1993 | A |
| 5245995 | Sullivan et al. | Sep 1993 | A |
| D340317 | Cole | Oct 1993 | S |
| 5259377 | Schroeder | Nov 1993 | A |
| 5269296 | Landis et al. | Dec 1993 | A |
| 5315859 | Schommer | May 1994 | A |
| 5349949 | Schegerin | Sep 1994 | A |
| 5366805 | Fujiki et al. | Nov 1994 | A |
| D354128 | Rinehart | Jan 1995 | S |
| D355484 | Rinehart | Feb 1995 | S |
| 5400776 | Bartholomew | Mar 1995 | A |
| 5429683 | Le Mitouard | Jul 1995 | A |
| 5438979 | Johnson et al. | Aug 1995 | A |
| 5441046 | Starr et al. | Aug 1995 | A |
| 5449206 | Lockwood | Sep 1995 | A |
| 5449234 | Gipp et al. | Sep 1995 | A |
| 5458202 | Fellows et al. | Oct 1995 | A |
| 5460174 | Chang | Oct 1995 | A |
| 5477852 | Landis et al. | Dec 1995 | A |
| 5513634 | Jackson | May 1996 | A |
| 5518802 | Colvin et al. | May 1996 | A |
| 5533506 | Wood | Jul 1996 | A |
| 5542128 | Lomas | Aug 1996 | A |
| 5551419 | Froehlich et al. | Sep 1996 | A |
| 5558090 | James | Sep 1996 | A |
| 5570689 | Starr et al. | Nov 1996 | A |
| 5588423 | Smith | Dec 1996 | A |
| 5595174 | Gwaltney | Jan 1997 | A |
| 5601078 | Schaller et al. | Feb 1997 | A |
| D378610 | Reischel et al. | May 1997 | S |
| 5649532 | Griffiths | Jul 1997 | A |
| 5657752 | Landis et al. | Aug 1997 | A |
| 5662101 | Ogden et al. | Sep 1997 | A |
| 5664566 | Mcdonald et al. | Sep 1997 | A |
| 5687715 | Landis | Nov 1997 | A |
| 5690097 | Howard | Nov 1997 | A |
| 5724965 | Handke et al. | Mar 1998 | A |
| 5746201 | Kidd | May 1998 | A |
| 5752510 | Goldstein | May 1998 | A |
| 5755578 | Contant et al. | May 1998 | A |
| 5806727 | Joseph | Sep 1998 | A |
| 5857460 | Popitz | Jan 1999 | A |
| 5884624 | Barnett et al. | Mar 1999 | A |
| 5904278 | Barlow et al. | May 1999 | A |
| 5918598 | Belfer | Jul 1999 | A |
| 5921239 | McCall et al. | Jul 1999 | A |
| 5941245 | Hannah et al. | Aug 1999 | A |
| 5943473 | Levine | Aug 1999 | A |
| 5953763 | Gouget | Sep 1999 | A |
| 5966745 | Schwartz et al. | Oct 1999 | A |
| 6016804 | Gleason et al. | Jan 2000 | A |
| 6017315 | Starr et al. | Jan 2000 | A |
| 6019101 | Cotner et al. | Feb 2000 | A |
| 6021528 | Jurga | Feb 2000 | A |
| 6039044 | Sullivan | Mar 2000 | A |
| 6050260 | Daniell et al. | Apr 2000 | A |
| 6112746 | Kwok et al. | Sep 2000 | A |
| 6116235 | Walters et al. | Sep 2000 | A |
| 6119693 | Kwok et al. | Sep 2000 | A |
| 6119694 | Correa et al. | Sep 2000 | A |
| 6135109 | Blasdell et al. | Oct 2000 | A |
| 6135432 | Hebblewhite et al. | Oct 2000 | A |
| 6192886 | Rudolph | Feb 2001 | B1 |
| D440302 | Wolfe | Apr 2001 | S |
| 6272933 | Gradon et al. | Aug 2001 | B1 |
| 6298850 | Argraves | Oct 2001 | B1 |
| 6302105 | Wickham et al. | Oct 2001 | B1 |
| 6341606 | Bordewick et al. | Jan 2002 | B1 |
| 6347631 | Hansen et al. | Feb 2002 | B1 |
| D455891 | Biedrzycki | Apr 2002 | S |
| 6398197 | Dickinson et al. | Jun 2002 | B1 |
| 6412487 | Gunaratnam et al. | Jul 2002 | B1 |
| 6412488 | Barnett | Jul 2002 | B1 |
| 6418928 | Bordewick et al. | Jul 2002 | B1 |
| 6427694 | Hecker et al. | Aug 2002 | B1 |
| 6431172 | Bordewick | Aug 2002 | B1 |
| 6435181 | Jones, Jr. et al. | Aug 2002 | B1 |
| 6439234 | Curti et al. | Aug 2002 | B1 |
| 6457473 | Brostrorn et al. | Oct 2002 | B1 |
| 6467483 | Kopacko et al. | Oct 2002 | B1 |
| 6470886 | Jestrabek-Hart | Oct 2002 | B1 |
| 6478026 | Wood | Nov 2002 | B1 |
| 6484725 | Chi et al. | Nov 2002 | B1 |
| 6488664 | Solomon et al. | Dec 2002 | B1 |
| 6491034 | Gunaratnam et al. | Dec 2002 | B1 |
| 6513526 | Kwok et al. | Feb 2003 | B2 |
| 6526978 | Dominguez | Mar 2003 | B2 |
| 6530373 | Patron et al. | Mar 2003 | B1 |
| 6561188 | Ellis | May 2003 | B1 |
| 6561190 | Kwok | May 2003 | B1 |
| 6561191 | Kwok | May 2003 | B1 |
| 6581594 | Drew et al. | Jun 2003 | B1 |
| 6581601 | Ziaee | Jun 2003 | B2 |
| 6581602 | Kwok et al. | Jun 2003 | B2 |
| 6584977 | Serowski | Jul 2003 | B1 |
| 6588424 | Bardel | Jul 2003 | B2 |
| 6615832 | Chen | Sep 2003 | B1 |
| 6629531 | Gleason et al. | Oct 2003 | B2 |
| 6631718 | Lovell | Oct 2003 | B1 |
| 6634358 | Kwok et al. | Oct 2003 | B2 |
| 6637434 | Noble | Oct 2003 | B2 |
| 6644315 | Ziaee | Nov 2003 | B2 |
| 6651658 | Hill | Nov 2003 | B1 |
| 6651663 | Barnett et al. | Nov 2003 | B2 |
| 6659102 | Sico | Dec 2003 | B1 |
| 6662803 | Gradon et al. | Dec 2003 | B2 |
| 6668828 | Figley et al. | Dec 2003 | B1 |
| D485905 | Moore | Jan 2004 | S |
| 6679257 | Robertson et al. | Jan 2004 | B1 |
| 6679265 | Strickland | Jan 2004 | B2 |
| 6691707 | Gunaratnam et al. | Feb 2004 | B1 |
| 6712072 | Lang | Mar 2004 | B1 |
| 6736139 | Wix | May 2004 | B1 |
| 6772761 | Rucker, Jr. | Aug 2004 | B1 |
| 6796308 | Gunaratnam et al. | Sep 2004 | B2 |
| 6817362 | Gelinas et al. | Nov 2004 | B2 |
| 6823869 | Raje et al. | Nov 2004 | B2 |
| 6851425 | Jaffre et al. | Feb 2005 | B2 |
| 6883177 | Ouellette et al. | Apr 2005 | B1 |
| 6892729 | Smith et al. | May 2005 | B2 |
| 6895965 | Scarberry et al. | May 2005 | B2 |
| 6907882 | Ging et al. | Jun 2005 | B2 |
| 6918390 | Lithgow et al. | Jul 2005 | B2 |
| 6951218 | Gradon et al. | Oct 2005 | B2 |
| 6953354 | Edirisuriya et al. | Oct 2005 | B2 |
| 6997187 | Wood et al. | Feb 2006 | B2 |
| 7004165 | Salcido | Feb 2006 | B1 |
| 7007696 | Palkon et al. | Mar 2006 | B2 |
| 7021311 | Gunaratnarn et al. | Apr 2006 | B2 |
| D520140 | Chaggares | May 2006 | S |
| 7066179 | Eaton et al. | Jun 2006 | B2 |
| 7077126 | Kummer et al. | Jul 2006 | B2 |
| D526094 | Chen | Aug 2006 | S |
| 7096864 | Mayer | Aug 2006 | B1 |
| D533269 | McAuley et al. | Dec 2006 | S |
| 7178525 | Matula, Jr. et al. | Feb 2007 | B2 |
| 7178528 | Lau | Feb 2007 | B2 |
| 7201169 | Wilkie et al. | Apr 2007 | B2 |
| 7207333 | Tohara | Apr 2007 | B2 |
| 7210481 | Lovell et al. | May 2007 | B1 |
| 7219669 | Lovell et al. | May 2007 | B1 |
| 7225811 | Ruiz et al. | Jun 2007 | B2 |
| 7255106 | Gallem et al. | Aug 2007 | B2 |
| 7287528 | Ho et al. | Oct 2007 | B2 |
| 7290546 | Sprinkle et al. | Nov 2007 | B2 |
| 7318437 | Gunaratnam et al. | Jan 2008 | B2 |
| 7353827 | Geist | Apr 2008 | B2 |
| 7357136 | Ho et al. | Apr 2008 | B2 |
| 7406966 | Wondka | Aug 2008 | B2 |
| 7448386 | Ho et al. | Nov 2008 | B2 |
| 7487772 | Ging et al. | Feb 2009 | B2 |
| 7493902 | White et al. | Feb 2009 | B2 |
| D589139 | Guney | Mar 2009 | S |
| 7523754 | Lithgow et al. | Apr 2009 | B2 |
| D595841 | McAuley et al. | Jul 2009 | S |
| 7562658 | Madaus et al. | Jul 2009 | B2 |
| 7597100 | Ging | Oct 2009 | B2 |
| 7640934 | Zollinger et al. | Jan 2010 | B2 |
| 7658189 | Davidson et al. | Feb 2010 | B2 |
| 7665464 | Kopacko et al. | Feb 2010 | B2 |
| D612933 | Prentice | Mar 2010 | S |
| 7681575 | Wixey et al. | Mar 2010 | B2 |
| 7694677 | Tang | Apr 2010 | B2 |
| 7703457 | Barnett et al. | Apr 2010 | B2 |
| 7753051 | Burrow et al. | Jul 2010 | B2 |
| D623288 | Lubke | Sep 2010 | S |
| 7814911 | Bordewick et al. | Oct 2010 | B2 |
| 7827990 | Melidis et al. | Nov 2010 | B1 |
| 7856982 | Matula et al. | Dec 2010 | B2 |
| 7877817 | Ho | Feb 2011 | B1 |
| 7896003 | Matula et al. | Mar 2011 | B2 |
| 7931024 | Ho et al. | Apr 2011 | B2 |
| 7934501 | Fu et al. | May 2011 | B2 |
| 7942150 | Guney et al. | May 2011 | B2 |
| 8042539 | Chandran et al. | Oct 2011 | B2 |
| 8042541 | Amarasinghe et al. | Oct 2011 | B2 |
| 8136524 | Ging et al. | Mar 2012 | B2 |
| 8136525 | Lubke et al. | Mar 2012 | B2 |
| D661796 | Andrews et al. | Jun 2012 | S |
| 8371302 | Ging et al. | Feb 2013 | B2 |
| 8397727 | Ng et al. | Mar 2013 | B2 |
| 8443807 | McAuley et al. | May 2013 | B2 |
| D686313 | Matula et al. | Jul 2013 | S |
| 8479726 | McAuley | Jul 2013 | B2 |
| 8479741 | McAuley et al. | Jul 2013 | B2 |
| 8567404 | Davidson et al. | Oct 2013 | B2 |
| 8631793 | Omura et al. | Jan 2014 | B2 |
| 8631799 | Davenport et al. | Jan 2014 | B2 |
| 8636005 | Gradon et al. | Jan 2014 | B2 |
| 8701667 | Ho et al. | Apr 2014 | B1 |
| 8714157 | McAuley et al. | May 2014 | B2 |
| 8720444 | Chang | May 2014 | B2 |
| 8757157 | Price et al. | Jun 2014 | B2 |
| 8783257 | McAuley et al. | Jul 2014 | B2 |
| 8869797 | Davidson et al. | Oct 2014 | B2 |
| 8869798 | Wells et al. | Oct 2014 | B2 |
| 8875709 | Davidson et al. | Nov 2014 | B2 |
| 8944061 | D'Souza et al. | Feb 2015 | B2 |
| 8950404 | Formica et al. | Feb 2015 | B2 |
| 8960196 | Henry | Feb 2015 | B2 |
| 9010331 | Lang et al. | Apr 2015 | B2 |
| 9027556 | Ng et al. | May 2015 | B2 |
| 9032955 | Lubke et al. | May 2015 | B2 |
| 9032956 | Scheiner et al. | May 2015 | B2 |
| 9072852 | McAuley et al. | Jul 2015 | B2 |
| 9119929 | McAuley et al. | Sep 2015 | B2 |
| 9119931 | D'Souza et al. | Sep 2015 | B2 |
| 9138555 | McAuley et al. | Sep 2015 | B2 |
| 9149596 | Valcic et al. | Oct 2015 | B2 |
| 9242062 | Melidis et al. | Jan 2016 | B2 |
| 9292799 | McAuley et al. | Mar 2016 | B2 |
| 9295799 | McAuley et al. | Mar 2016 | B2 |
| 9302065 | Smith et al. | Apr 2016 | B2 |
| 9320566 | Alston, Jr. | Apr 2016 | B1 |
| 9320866 | McAuley et al. | Apr 2016 | B2 |
| 9333315 | McAuley et al. | May 2016 | B2 |
| 9339622 | McAuley et al. | May 2016 | B2 |
| 9339624 | McAuley | May 2016 | B2 |
| 9375545 | Darkin et al. | Jun 2016 | B2 |
| 9381316 | Ng et al. | Jul 2016 | B2 |
| 9457162 | Ging et al. | Oct 2016 | B2 |
| 9486601 | Stallard et al. | Nov 2016 | B2 |
| 9517317 | McAuley et al. | Dec 2016 | B2 |
| 9522246 | Frater et al. | Dec 2016 | B2 |
| 9539405 | McAuley et al. | Jan 2017 | B2 |
| 9550038 | McAuley et al. | Jan 2017 | B2 |
| 9561338 | McAuley et al. | Feb 2017 | B2 |
| 9561339 | McAuley | Feb 2017 | B2 |
| 9744385 | Henry et al. | Aug 2017 | B2 |
| 9884160 | McAuley et al. | Feb 2018 | B2 |
| 9901700 | McAuley et al. | Feb 2018 | B2 |
| 9907925 | McAuley et al. | Mar 2018 | B2 |
| 9974914 | McAuley | May 2018 | B2 |
| 10080856 | McLaren et al. | Sep 2018 | B2 |
| 20010017134 | Bahr | Aug 2001 | A1 |
| 20010020474 | Hecker et al. | Sep 2001 | A1 |
| 20010029952 | Curran | Oct 2001 | A1 |
| 20020014241 | Gradon et al. | Feb 2002 | A1 |
| 20020020416 | Namey | Feb 2002 | A1 |
| 20020026934 | Lithgow et al. | Mar 2002 | A1 |
| 20020029780 | Frater et al. | Mar 2002 | A1 |
| 20020046755 | Voss | Apr 2002 | A1 |
| 20020053347 | Ziaee | May 2002 | A1 |
| 20020059935 | Wood | May 2002 | A1 |
| 20020096176 | Gunaratnam et al. | Jul 2002 | A1 |
| 20020096178 | Ziaee | Jul 2002 | A1 |
| 20020100474 | Kellner et al. | Aug 2002 | A1 |
| 20020100479 | Scarberry et al. | Aug 2002 | A1 |
| 20020108613 | Gunaratnam et al. | Aug 2002 | A1 |
| 20030005509 | Kelzer | Jan 2003 | A1 |
| 20030005931 | Jaffre et al. | Jan 2003 | A1 |
| 20030005933 | Izuchukwu | Jan 2003 | A1 |
| 20030019495 | Palkon et al. | Jan 2003 | A1 |
| 20030019496 | Kopacko et al. | Jan 2003 | A1 |
| 20030029454 | Gelinas et al. | Feb 2003 | A1 |
| 20030047185 | Olsen et al. | Mar 2003 | A1 |
| 20030075182 | Heidmann et al. | Apr 2003 | A1 |
| 20030079749 | Strickland et al. | May 2003 | A1 |
| 20030089373 | Gradon et al. | May 2003 | A1 |
| 20030094177 | Smith et al. | May 2003 | A1 |
| 20030121519 | Estes et al. | Jul 2003 | A1 |
| 20030149384 | Davis et al. | Aug 2003 | A1 |
| 20030164170 | Resmed | Sep 2003 | A1 |
| 20030172936 | Wilkie et al. | Sep 2003 | A1 |
| 20030196655 | Ging et al. | Oct 2003 | A1 |
| 20030196656 | Moore | Oct 2003 | A1 |
| 20030196658 | Ging et al. | Oct 2003 | A1 |
| 20030196659 | Gradon et al. | Oct 2003 | A1 |
| 20030196664 | Jacobson | Oct 2003 | A1 |
| 20030200970 | Stenzler et al. | Oct 2003 | A1 |
| 20030217746 | Gradon et al. | Nov 2003 | A1 |
| 20030221691 | Biener | Dec 2003 | A1 |
| 20040025882 | Madaus et al. | Feb 2004 | A1 |
| 20040035427 | Bordewick et al. | Feb 2004 | A1 |
| 20040065328 | Amarasinghe et al. | Apr 2004 | A1 |
| 20040067333 | Amarasinghe | Apr 2004 | A1 |
| 20040107968 | Griffiths | Jun 2004 | A1 |
| 20040112377 | Arnarasinghe et al. | Jun 2004 | A1 |
| 20040112384 | Lithgow et al. | Jun 2004 | A1 |
| 20040112385 | Drew | Jun 2004 | A1 |
| 20040113406 | Lithgow | Jun 2004 | A1 |
| 20040118412 | Piletti-Reyes | Jun 2004 | A1 |
| 20040139973 | Wright | Jul 2004 | A1 |
| 20040149280 | Semeniuk | Aug 2004 | A1 |
| 20040182398 | Sprinkle et al. | Sep 2004 | A1 |
| 20040211427 | Jones et al. | Oct 2004 | A1 |
| 20040221850 | Ging et al. | Nov 2004 | A1 |
| 20040226566 | Gunaratnam et al. | Nov 2004 | A1 |
| 20040255949 | Lang et al. | Dec 2004 | A1 |
| 20050011521 | Sprinkle et al. | Jan 2005 | A1 |
| 20050011524 | Thomlinson et al. | Jan 2005 | A1 |
| 20050016532 | Farrell | Jan 2005 | A1 |
| 20050028822 | Sleeper et al. | Feb 2005 | A1 |
| 20050033247 | Thompson | Feb 2005 | A1 |
| 20050045182 | Wood et al. | Mar 2005 | A1 |
| 20050051177 | Wood | Mar 2005 | A1 |
| 20050066976 | Wondka | Mar 2005 | A1 |
| 20050076913 | Ho et al. | Apr 2005 | A1 |
| 20050092327 | Fini et al. | May 2005 | A1 |
| 20050098183 | Nash et al. | May 2005 | A1 |
| 20050121037 | Wood | Jun 2005 | A1 |
| 20050133038 | Rutter | Jun 2005 | A1 |
| 20050150497 | Eifler et al. | Jul 2005 | A1 |
| 20050155604 | Ging et al. | Jul 2005 | A1 |
| 20050172969 | Ging | Aug 2005 | A1 |
| 20050199239 | Lang et al. | Sep 2005 | A1 |
| 20050199242 | Matula et al. | Sep 2005 | A1 |
| 20050205096 | Matula | Sep 2005 | A1 |
| 20050235999 | Wood et al. | Oct 2005 | A1 |
| 20050241644 | Guney et al. | Nov 2005 | A1 |
| 20060032504 | Burton et al. | Feb 2006 | A1 |
| 20060042629 | Geist | Mar 2006 | A1 |
| 20060042632 | Bishop et al. | Mar 2006 | A1 |
| 20060054169 | Han et al. | Mar 2006 | A1 |
| 20060060200 | Ho et al. | Mar 2006 | A1 |
| 20060076019 | Ho | Apr 2006 | A1 |
| 20060081256 | Palmer | Apr 2006 | A1 |
| 20060096598 | Ho et al. | May 2006 | A1 |
| 20060107958 | Sleeper | May 2006 | A1 |
| 20060118117 | Berthon-Jones et al. | Jun 2006 | A1 |
| 20060124131 | Chandran | Jun 2006 | A1 |
| 20060130844 | Ho et al. | Jun 2006 | A1 |
| 20060137690 | Gunaratnam et al. | Jun 2006 | A1 |
| 20060169286 | Eifler et al. | Aug 2006 | A1 |
| 20060174887 | Chandran et al. | Aug 2006 | A1 |
| 20060196511 | Lau et al. | Sep 2006 | A1 |
| 20060201514 | Jones et al. | Sep 2006 | A1 |
| 20060225740 | Eaton et al. | Oct 2006 | A1 |
| 20060231103 | Matula et al. | Oct 2006 | A1 |
| 20060237017 | Davidson et al. | Oct 2006 | A1 |
| 20060237018 | McAuley et al. | Oct 2006 | A1 |
| 20060249159 | Ho | Nov 2006 | A1 |
| 20060254593 | Chang | Nov 2006 | A1 |
| 20060266361 | Hernandez | Nov 2006 | A1 |
| 20060283459 | Geiselhart et al. | Dec 2006 | A1 |
| 20060283461 | Lubke et al. | Dec 2006 | A1 |
| 20070000492 | Hansel et al. | Jan 2007 | A1 |
| 20070010786 | Casey et al. | Jan 2007 | A1 |
| 20070044804 | Matula et al. | Mar 2007 | A1 |
| 20070062536 | McAuley | Mar 2007 | A1 |
| 20070089749 | Ho et al. | Apr 2007 | A1 |
| 20070107733 | Ho | May 2007 | A1 |
| 20070125384 | Zollinger et al. | Jun 2007 | A1 |
| 20070125385 | Ho et al. | Jun 2007 | A1 |
| 20070125387 | Zollinger et al. | Jun 2007 | A1 |
| 20070137653 | Wood | Jun 2007 | A1 |
| 20070142785 | Lundgaard | Jun 2007 | A1 |
| 20070157353 | Guney et al. | Jul 2007 | A1 |
| 20070163600 | Hoffman | Jul 2007 | A1 |
| 20070174952 | Jacob | Aug 2007 | A1 |
| 20070175480 | Gradon et al. | Aug 2007 | A1 |
| 20070209663 | Marque et al. | Sep 2007 | A1 |
| 20070215161 | Frater et al. | Sep 2007 | A1 |
| 20070221227 | Ho | Sep 2007 | A1 |
| 20070227541 | Van den Akker | Oct 2007 | A1 |
| 20070295335 | Nashed | Dec 2007 | A1 |
| 20080035152 | Ho et al. | Feb 2008 | A1 |
| 20080041388 | McAuley et al. | Feb 2008 | A1 |
| 20080041393 | Bracken | Feb 2008 | A1 |
| 20080047560 | Veliss et al. | Feb 2008 | A1 |
| 20080060648 | Thornton et al. | Mar 2008 | A1 |
| 20080060653 | Hallett et al. | Mar 2008 | A1 |
| 20080060657 | McAuley et al. | Mar 2008 | A1 |
| 20080083412 | Henry et al. | Apr 2008 | A1 |
| 20080099024 | Gunaratnam et al. | May 2008 | A1 |
| 20080105257 | Klasek et al. | May 2008 | A1 |
| 20080110464 | Davidson et al. | May 2008 | A1 |
| 20080142019 | Lewis | Jun 2008 | A1 |
| 20080171737 | Fensorne | Jul 2008 | A1 |
| 20080178875 | Henry | Jul 2008 | A1 |
| 20080178886 | Lieberman et al. | Jul 2008 | A1 |
| 20080190432 | Biochlinger et al. | Aug 2008 | A1 |
| 20080190436 | Jaffe et al. | Aug 2008 | A1 |
| 20080196728 | Ho | Aug 2008 | A1 |
| 20080210241 | Schulz et al. | Sep 2008 | A1 |
| 20080223370 | Kim | Sep 2008 | A1 |
| 20080236586 | Mcdonald et al. | Oct 2008 | A1 |
| 20080257354 | Davidson | Oct 2008 | A1 |
| 20080264422 | Fishman | Oct 2008 | A1 |
| 20080276937 | Davidson et al. | Nov 2008 | A1 |
| 20080302366 | McGinnis et al. | Dec 2008 | A1 |
| 20080314388 | Brambilla et al. | Dec 2008 | A1 |
| 20080319334 | Yamamori | Dec 2008 | A1 |
| 20090014007 | Brambilla et al. | Jan 2009 | A1 |
| 20090032024 | Burz et al. | Feb 2009 | A1 |
| 20090044808 | Guney et al. | Feb 2009 | A1 |
| 20090078267 | Burz et al. | Mar 2009 | A1 |
| 20090107504 | McAuley et al. | Apr 2009 | A1 |
| 20090114227 | Gunaratnam et al. | May 2009 | A1 |
| 20090120442 | Ho | May 2009 | A1 |
| 20090126739 | Ng et al. | May 2009 | A1 |
| 20090133697 | Kwok et al. | May 2009 | A1 |
| 20090139527 | Ng et al. | Jun 2009 | A1 |
| 20090145429 | Ging et al. | Jun 2009 | A1 |
| 20090151729 | Judson et al. | Jun 2009 | A1 |
| 20090173349 | Hernandez et al. | Jul 2009 | A1 |
| 20090183739 | Wondka | Jul 2009 | A1 |
| 20090223519 | Eifler et al. | Sep 2009 | A1 |
| 20100000538 | Edwards et al. | Jan 2010 | A1 |
| 20100000539 | Woodard | Jan 2010 | A1 |
| 20100051031 | Lustenberger et al. | Mar 2010 | A1 |
| 20100083961 | McAuley et al. | Apr 2010 | A1 |
| 20100108072 | D'Souza | May 2010 | A1 |
| 20100132717 | Davidson et al. | Jun 2010 | A1 |
| 20100154798 | Henry et al. | Jun 2010 | A1 |
| 20100170516 | Grane | Jul 2010 | A1 |
| 20100199992 | Ho | Aug 2010 | A1 |
| 20100229868 | Rummery et al. | Sep 2010 | A1 |
| 20100258132 | Moore | Oct 2010 | A1 |
| 20100258136 | Doherty et al. | Oct 2010 | A1 |
| 20100294281 | Ho | Nov 2010 | A1 |
| 20100307502 | Rummery | Dec 2010 | A1 |
| 20100313891 | Veliss et al. | Dec 2010 | A1 |
| 20100319700 | Ng et al. | Dec 2010 | A1 |
| 20100326445 | Veliss et al. | Dec 2010 | A1 |
| 20110072553 | Ho | Mar 2011 | A1 |
| 20110088699 | Skipper | Apr 2011 | A1 |
| 20110146685 | Allan et al. | Jun 2011 | A1 |
| 20110232649 | Collazo et al. | Sep 2011 | A1 |
| 20110265796 | Amarasinghe et al. | Nov 2011 | A1 |
| 20110290253 | McAuley | Dec 2011 | A1 |
| 20110308520 | McAuley et al. | Dec 2011 | A1 |
| 20120125339 | Ho et al. | May 2012 | A1 |
| 20120132208 | Judson et al. | May 2012 | A1 |
| 20120132209 | Rummery | May 2012 | A1 |
| 20120138061 | Dravitzki et al. | Jun 2012 | A1 |
| 20120204879 | Cariola et al. | Aug 2012 | A1 |
| 20120285457 | Mansour et al. | Nov 2012 | A1 |
| 20120304999 | Swift et al. | Dec 2012 | A1 |
| 20120318270 | McAuley et al. | Dec 2012 | A1 |
| 20130133659 | Ng et al. | May 2013 | A1 |
| 20130133664 | Startare | May 2013 | A1 |
| 20130152918 | Rummery et al. | Jun 2013 | A1 |
| 20130160769 | Ng et al. | Jun 2013 | A1 |
| 20140026888 | Matula | Jan 2014 | A1 |
| 20140083428 | Rothermel et al. | Mar 2014 | A1 |
| 20140083430 | Matula, Jr. et al. | Mar 2014 | A1 |
| 20140137870 | Barlow et al. | May 2014 | A1 |
| 20140311492 | Stuebiger et al. | Oct 2014 | A1 |
| 20140338672 | D'Souza et al. | Nov 2014 | A1 |
| 20150013678 | McAuley | Jan 2015 | A1 |
| 20150033457 | Tryner et al. | Feb 2015 | A1 |
| 20150090266 | Melidis et al. | Apr 2015 | A1 |
| 20150297855 | McAuley et al. | Oct 2015 | A1 |
| 20150335846 | Romagnoli et al. | Nov 2015 | A1 |
| 20150352308 | Cullen et al. | Dec 2015 | A1 |
| 20150374944 | Edwards et al. | Dec 2015 | A1 |
| 20150374946 | McAuley et al. | Dec 2015 | A1 |
| 20160001028 | McAuley et al. | Jan 2016 | A1 |
| 20160008558 | Huddart et al. | Jan 2016 | A1 |
| 20160038705 | McAuley et al. | Feb 2016 | A1 |
| 20160038706 | McAuley et al. | Feb 2016 | A1 |
| 20160038707 | Allan et al. | Feb 2016 | A1 |
| 20160051786 | McAuley et al. | Feb 2016 | A1 |
| 20160106944 | McAuley et al. | Apr 2016 | A1 |
| 20160166792 | Allan et al. | Jun 2016 | A1 |
| 20160213873 | McAuley et al. | Jul 2016 | A1 |
| 20160213874 | Davidson et al. | Jul 2016 | A1 |
| 20160296720 | Henry et al. | Oct 2016 | A1 |
| 20170028148 | McAuley et al. | Feb 2017 | A1 |
| 20170072155 | Allan et al. | Mar 2017 | A1 |
| 20170119988 | Allan et al. | May 2017 | A1 |
| 20170143925 | McAuley et al. | May 2017 | A1 |
| 20170239438 | McAuley et al. | Aug 2017 | A1 |
| 20170304574 | McAuley et al. | Oct 2017 | A1 |
| 20170326325 | Allan et al. | Nov 2017 | A1 |
| 20180221615 | McAuley et al. | Aug 2018 | A1 |
| Number | Date | Country |
|---|---|---|
| 2003246441 | Dec 2003 | AU |
| 131 16 62 | Dec 1992 | CA |
| 000966064-0001 | Sep 2008 | CD |
| 000966064-0002 | Sep 2008 | CD |
| 000966064-0003 | Sep 2008 | CD |
| 000966064-0004 | Sep 2008 | CD |
| 000966064-0017 | Sep 2008 | CD |
| 217 253 8 | Jul 1994 | CN |
| 101115521 | Dec 2003 | CN |
| 1784250 | Jun 2006 | CN |
| 1901961 | Jan 2007 | CN |
| 1988930 | Jun 2007 | CN |
| 101214402 | Jul 2008 | CN |
| 101541380 | Sep 2009 | CN |
| 895692 | Nov 1953 | DE |
| 29723101 | Jul 1998 | DE |
| 19603949 | Nov 1998 | DE |
| 10312881 | May 2004 | DE |
| 102006011151 | Sep 2007 | DE |
| 0 350 322 | Jan 1990 | EP |
| 0 427 474 | May 1991 | EP |
| 0 462 701 | Dec 1991 | EP |
| 0747078 | Dec 1996 | EP |
| 1 099 452 | May 2001 | EP |
| 0 830 180 | Mar 2002 | EP |
| 1 258 266 | Nov 2002 | EP |
| 1 582 231 | Oct 2005 | EP |
| 2 042 209 | Apr 2009 | EP |
| 1488820 | Sep 2009 | EP |
| 2130563 | Dec 2009 | EP |
| 2 145 645 | Jan 2010 | EP |
| 1 753 495 | Sep 2010 | EP |
| 1 481 702 | Sep 2012 | EP |
| 2 749 176 | Jul 2014 | EP |
| 1646910 | Aug 2015 | EP |
| 2 022 528 | Mar 2016 | EP |
| 2658725 | Aug 1991 | FR |
| 2749176 | Dec 1997 | FR |
| 190 224 431 | Dec 1902 | GB |
| 880 824 | Oct 1961 | GB |
| 979357 | Jan 1965 | GB |
| 1 467 828 | Mar 1977 | GB |
| 2133275 | Jul 1984 | GB |
| 2173274 | Oct 1986 | GB |
| 2186801 | Aug 1987 | GB |
| H09-010311 | Jan 1997 | JP |
| 2000-325481 | Nov 2000 | JP |
| 2004-016488 | Jan 2004 | JP |
| 2005-529687 | Oct 2005 | JP |
| 2005-537906 | Dec 2005 | JP |
| 2007-516750 | Jun 2007 | JP |
| 2007-527271 | Sep 2007 | JP |
| 531332 | Feb 2004 | NZ |
| 534606 | Aug 2004 | NZ |
| 528029 | Mar 2005 | NZ |
| 548575 | Jul 2006 | NZ |
| 551103 | Nov 2006 | NZ |
| WO 82003548 | Oct 1982 | WO |
| WO 9732494 | Sep 1997 | WO |
| WO 9804310 | Feb 1998 | WO |
| WO 9804311 | Feb 1998 | WO |
| WO 1998018514 | May 1998 | WO |
| WO 98024499 | Jun 1998 | WO |
| WO 98048878 | Nov 1998 | WO |
| WO 9857691 | Dec 1998 | WO |
| WO 199904842 | Feb 1999 | WO |
| WO 9943375 | Sep 1999 | WO |
| WO 99058198 | Nov 1999 | WO |
| WO 1999058181 | Nov 1999 | WO |
| WO 00050122 | Jun 2000 | WO |
| WO 00057942 | Oct 2000 | WO |
| WO 00069497 | Nov 2000 | WO |
| WO 2000069497 | Nov 2000 | WO |
| WO 00078384 | Dec 2000 | WO |
| WO 2000074758 | Dec 2000 | WO |
| WO 0100266 | Jan 2001 | WO |
| WO 0132250 | May 2001 | WO |
| WO 2001041854 | Jun 2001 | WO |
| WO 01058293 | Aug 2001 | WO |
| WO 01062326 | Aug 2001 | WO |
| WO 01097892 | Dec 2001 | WO |
| WO 01097893 | Dec 2001 | WO |
| WO 2001097892 | Dec 2001 | WO |
| WO 02005883 | Jan 2002 | WO |
| WO 02011804 | Feb 2002 | WO |
| WO 02047749 | Jun 2002 | WO |
| WO 2002074372 | Sep 2002 | WO |
| WO 03035156 | May 2003 | WO |
| WO 03092755 | Nov 2003 | WO |
| WO 04007010 | Jan 2004 | WO |
| WO 04096332 | Jan 2004 | WO |
| WO 04022147 | Mar 2004 | WO |
| WO 04030736 | Apr 2004 | WO |
| WO 04041342 | May 2004 | WO |
| WO 2004041341 | May 2004 | WO |
| WO 04073777 | Sep 2004 | WO |
| WO 2004073778 | Sep 2004 | WO |
| WO 05010608 | Feb 2005 | WO |
| WO 05018523 | Mar 2005 | WO |
| WO 2005021075 | Mar 2005 | WO |
| WO 2005051468 | Jun 2005 | WO |
| WO 05063326 | Jul 2005 | WO |
| WO 05063328 | Jul 2005 | WO |
| WO 05079726 | Sep 2005 | WO |
| WO 2005086946 | Sep 2005 | WO |
| WO 05097247 | Oct 2005 | WO |
| WO 05123166 | Dec 2005 | WO |
| WO 06000046 | Jan 2006 | WO |
| WO 06050559 | May 2006 | WO |
| WO 06069415 | Jul 2006 | WO |
| WO 06074513 | Jul 2006 | WO |
| WO 06074514 | Jul 2006 | WO |
| WO 06074515 | Jul 2006 | WO |
| WO 06096924 | Sep 2006 | WO |
| WO 06130903 | Dec 2006 | WO |
| WO 06138346 | Dec 2006 | WO |
| WO 06138416 | Dec 2006 | WO |
| WO 07006089 | Jan 2007 | WO |
| WO 07009182 | Jan 2007 | WO |
| WO 07021777 | Jan 2007 | WO |
| WO 2007022562 | Mar 2007 | WO |
| WO 07041751 | Apr 2007 | WO |
| WO 07045008 | Apr 2007 | WO |
| WO 2007041786 | Apr 2007 | WO |
| WO 07048174 | May 2007 | WO |
| WO 07053878 | May 2007 | WO |
| WO 2007147088 | Dec 2007 | WO |
| WO 2008007985 | Jan 2008 | WO |
| WO 08014543 | Feb 2008 | WO |
| WO 08030831 | Mar 2008 | WO |
| WO 2008060295 | May 2008 | WO |
| WO 08068966 | Jun 2008 | WO |
| WO 2008070929 | Jun 2008 | WO |
| WO 2008106716 | Sep 2008 | WO |
| WO 2008148086 | Dec 2008 | WO |
| WO 09026627 | Mar 2009 | WO |
| WO 2009052560 | Apr 2009 | WO |
| WO 2009059353 | May 2009 | WO |
| WO 2009092057 | Jul 2009 | WO |
| WO 2009139647 | Nov 2009 | WO |
| WO 10066004 | Jun 2010 | WO |
| WO 10131189 | Nov 2010 | WO |
| WO 10135785 | Dec 2010 | WO |
| WO 11014931 | Feb 2011 | WO |
| WO 11059346 | May 2011 | WO |
| WO 11060479 | May 2011 | WO |
| WO 12045127 | Apr 2012 | WO |
| WO 12052902 | Apr 2012 | WO |
| WO 12143822 | Oct 2012 | WO |
| WO 14020469 | Feb 2014 | WO |
| WO 14175752 | Oct 2014 | WO |
| WO 14175753 | Oct 2014 | WO |
| WO 15033287 | Mar 2015 | WO |
| WO 16000040 | Jan 2016 | WO |
| WO 17049356 | Mar 2017 | WO |
| WO 17049357 | Mar 2017 | WO |
| Entry |
|---|
| International Preliminary Report on Patentability (IPRP), International Application No. PCT/NZ2009/000219, dated Apr. 12, 2011, 9 pages. |
| International Search Report, International Application No. PCT/NZ2009/000219, dated Feb. 2, 2010, 3 pages. |
| Office Action with English Translation; Chinese Application No. 2007800266164; 5 pages. |
| First Office Action with English Translation; Chinese Application No. 201210080441.8, dated Mar. 24, 2014, 4 pages. |
| Office Action; Australian Application No. 2007273324; dated May 22, 2012; 3 pages. |
| International Search Report, International Application No. PCT/NZ2007/000185, dated Oct. 31, 2007, 3 pages. |
| Second Office Action with English Translation, Chinese Application No. 201210080441.8, dated Dec. 1, 2014, 11 pages. |
| Office Action. Australian Application No. 2012265597, dated Dec. 19, 2013, 5 pages. |
| Office Action, Canadian Application No. 2655839, dated Oct. 4, 2013, 2 pages. |
| International Search Report; PCT/NZ2009/000072; dated Jul. 28, 2009; 3 pages. |
| Office Action; GB Application No. GB1210075.6; dated Mar. 14, 2013; 2 pages. |
| Office Action; GB Application No. GB1119385.1; dated May 9, 2013; 4 pages. |
| Office Action; Australian Application No. 2010246985; dated Mar. 4, 2014; 5 pages. |
| Office Action with Translation; Japanese Application No. 2012-510418; dated Feb. 10, 2014; 4 pages. |
| Office Action; Chinese Application No. 201080028029.0; dated Mar. 27, 2014; 16 pages. |
| Office Action; GB Application No. GB1406402.6; dated May 7, 2014; 6 pages. |
| Office Action; GB Application No. GB1406401.8; dated May 7, 2014; 4 pages. |
| Office Action; Japanese Application No. 2012-538784; 3 pages. |
| Office Action; Australian Application No. 2015202814; dated Aug. 14, 2015; 8 pages. |
| Office Action; Chinese Application No. 201080061122.1; dated Jul. 17, 2015; 10 pages. |
| Office Action; Chinese Application No. 201080028029.0; dated Sep. 14, 2015; 3 pages. |
| Extended Search Report; European Application No. 10830251.4; dated Sep. 4, 2015; 7 pages. |
| Extended Search Report; European Application No. 10774623.2; dated Sep. 8, 2015; 7 pages. |
| Office Action; Japanese Application No. 2015-098324; dated Jul. 22, 2015; 8 pages. |
| Office Action; Japanese Application No. 2012-538784; dated Aug. 5, 2015; 8 pages. |
| Office Action; Australian Application No. 2010241390; dated Jan. 9, 2015; 4 pages. |
| Office Action with English Translation; Chinese Application No. 201080061122.1; dated Sep. 3, 2015; 9 pages. |
| Second Office Action with English Translation; Chinese Application No. 201080028029.0; dated Jan. 19, 2015; 16 pages. |
| Search Report; European Application No. 09819444.2; dated Apr. 2, 2014; 8 pages. |
| Office Action; Australian Application No. 20015201920; dated Jul. 20, 2015; 3 pages. |
| Office Action; European Application No. 07808683.2; dated Jul. 8, 2015; 8 pages. |
| Office Action; Canadian Application No. 2890556; dated Jan. 27, 2016; 3 pages. |
| Third Office Action; Chinese Application No. 201080061122.1; dated Apr. 1, 2016; 5 pages. |
| International Preliminary Report on Patentability and Written Opinion of the ISA; International application No. PCT/NZ2010/000229; dated May 22, 2012; 14 pages. |
| International Search Report, Int'l application No. PCT/NZ2010/000229, dated Mar. 18, 2011; 8 pages. |
| Written Opinion of the International Searching Authority; PCT/NZ2010/000229; dated Mar. 18, 2011; 13 pages. |
| Fisher & Paykel HC200 Series Nasal CPAP Blower & Heated Humidifier User Manual, 17 pp., May 1998. |
| Fisher & Paykel MR810 Manual, Rev. C, 2004, 43 pp. |
| HomeDepot.com—Ring Nut Sales Page (Retrieved Oct. 16, 2015 from http://www.homedepot.com/p/Everbilt-1-2-in-Galvanized-HexNut-804076/20464-7893), 4 pp. |
| Malloy, 1994, Plastic Part Design for Injection Molding, Hanswer Gardner Publications, Inc, Cincinnati, OH, 14 pp. |
| Merriam-Webster's Collegiate Dictionary, Eleventh Edition, 2004, pp. 703, 905, 1074, 1184. |
| ResMed FlexiFit brochure. |
| ResMed Exhibit, FlexiFit™ 431, product brochure, web pages (Wayback Machine), 2006, 23 pp. |
| ResMed Origins Brochure (Retrieved Apr. 17, 2016 from http://www.resmed.com/us/dam/documents/articles/resmedorigins.pdf), 64 pp. |
| ResMed Ultra Mirage™ Full Face Mask, product brochure, 2004, 2 pp. |
| ResMed Ultra Mirage™ Full Face Mask, product brochure, web pages (Wayback Machine), 2006, 9 pp. |
| ResMed, Jun. 29, 1997, Mask Frames (Source: Wayback Machine Internet Archive); http://web.archive.org/web/19970629053430/http://www.resmed.com- /maskframes/mask.htm, 2 pp/. |
| ResMed, Mirage Swift™ Nasal Pillows System from ResMed, product brochure, 2004, 6 pp. |
| ResMed, Mirage Swift™ Nasal Pillows System: User's Guide, product brochure, 2004,11 pp. |
| ResMed, Mirage Vista™ Nasal Mask: Components Card, product brochure, 2005, 1 p. |
| The American Heritage Dictionary of the English Language, Fourth Edition, 2006, pp. 1501, 1502, 1650. |
| WeddingBands.com—Men's Wedding Ring Shopping Page (Retrieved Oct. 16, 2015 from http://www.weddingbands.com/ProductPop.sub.—wedding.sub.—band- s.sub.—meta1/48214W.html), 3 pp. |
| Australian Examination Report in patent application No. 2015201920, dated Jul. 20, 2015, 3 pages. |
| Canadian Examination Report in patent application No. 2890556, dated Jan. 27, 2016, 3 pages. |
| Chinese First Office Action in patent application No. 201210080441.8, dated Mar. 24, 2014, 4 pages. |
| Chinese Second Office Action in patent application No. 201080028029,0, dated Jan. 19, 2015, 16 pages. |
| European Extended Search Report; dated Apr. 2, 2014; Application No. 09819444.2; 8 pages. |
| European Examination Report in patent application No. 07808683.2, dated Jul. 8, 2015, 8 pages. |
| International Search Report, PCT/NZ2010/000229, dated Mar. 18, 2011, 8 pages. |
| Japanese Examination Report in patent application No. 2012-536784, dated Aug. 5, 2015, 8 pages. |
| Petition for Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 35 U.S.G. §§ 311-19, 37 C.F.R. § 42, IPR2016-01714, dated Sep. 7, 2016. |
| Declaration of Dr. John Izuchukwu, Pri.D., P.E,, U.S. Pat. No. 8,443,807, IPR Nos. 2016-1726 & 2016-1734, dated Sep. 7, 2016. |
| Declaration of Dr. John Izuchukwu, Ph.D,, Re., U.S. Pat, No. 8,479,741, IPR Nos. 2016-1714 & 2016-1718, dated Sep. 7, 2016. |
| Petition for Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01718, dated Sep. 7, 2016. |
| Petition for Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01726, dated Sep. 7, 2016. |
| Petition for Inter Partes Review of U.S. Pat. No, 8,443,807 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01734, dated Sep. 7, 2016. |
| File History of U.S. Pat. No. 8,479,741 to McAuley et al, published Oct. 1, 2009. |
| File History of U.S. Pat. No, 8,443,607 to McAuley et al, published Jan. 7, 2010. |
| Patent Owner's Complaint for Fisher & Paykel Healthcare Ltd. v. ResMed Corp., Case No. 2:16-cv-06099-R-AJW (C,D. Cal.), dated Aug. 15, 2016. |
| Patent Owner's Notice of Voluntary Dismissal Without Prejudice for Fisher & Paykel Healthcare Ltd, v. ResMed Corp., Case No. 2:16-cv-06099-R-AJW (C.D. Cal.), dated Aug. 16, 2016. |
| Patent Owner's Complaint for Fisher & Paykel Healthcare Ltd. v. ResMed Corp., Case No. 3:16-cv-02068-GPC-WVG (S.D. Cal.), dated Aug. 16, 2016. |
| Petitioners' Complaint for ResMed Inc., et al. v. Fisher & Paykel Healthcare Corp. Ltd., et al., Case No. 3:16-cv-02072-JAH-MDD (S.D. Cal.), dated Aug. 16, 2016. |
| Petitioners' Notice of Voluntary Dismissal Without Prejudice for ResMed Inc., et al. v. Fisher & Paykel Healthcare Corp. Ltd., et al., Case No. 3:16-cv-02072-JAH-MDD (S.D, Cal.) , dated Aug. 18, 2016. |
| Statutory Declaration made by Alistair Edwin McAuley, Apr. 9, 2015, in the matter of an Opposition by Fisher & Paykel Healthcare Limited of Australian patent application 2009221630 in the name of ResMed Limited. |
| Fisher & Paykel Healthcare, FlexiFit® 431 Full Face Mask instructions, 2010, 4 pp. |
| Fisher & Paykel Healthcare, FlexiFit™ 431 Full Face Mask, specification sheet, 2004, 2 pp. |
| Fisher & Paykel Healthcare; Interface Solutions Product Profile, 2006, 12 pp. |
| Philips Respironics ‘System One Heated Humidifier—User Manual’, 2011, pp. 1-16, [retrieved on Nov, 25, 2013] from the internet: URL: http://www.cpapxchange.com/cpap-machines-biap-machines/system-one-60-seri- es-cpap-humidifier-manual.pdf front cover, pp. 3-4 and 6. |
| Australian Examination Report in patent application No. 2016238904 dated May 4, 2018, 5 pages. |
| Australian Examination Report in patent application No. 2010241390, dated Sep. 28, 2016, 4 pages. |
| Australian Examination Report in patent application No. 2016202799, dated May 31, 2016, 2 pages. |
| Australian examination report in patent application No. 2016202801, dated Jun. 20, 2016, 2 pages. |
| Australian Examination Report in patent application No. 2016204384, dated Aug. 5, 2016, 2 pages. |
| Australian examination report in patent application No. 2017200991, dated Oct. 13, 2017, 3 pages. |
| Australian examination report in patent application No. 2017201021, dated Apr. 7, 2017, 6 pages. |
| Canadian Examination Report in patent application No. 2780310, dated Jul. 26, 2016, 4 pages. |
| Canadian Examination Report in patent application No. 2780310, dated Jan. 25, 2018 4 pages. |
| Canadian Examination Report in patent application No. 2690556, dated Nov. 28, 2016, 4 pages. |
| Canadian Examination Report in patent application No. 2918167, dated Oct. 3, 2016, 4 pages. |
| Chinese Office Action in patent application No. 201610116121.1, dated Sep. 28, 2017, 5 pages. |
| Chinese Third Office Action in patent application No. 201030061122.1, dated Apr. 1, 2016, 5 pages. |
| European Examination Report in patent application No. 07308683,2, dated May 9, 2016, 3 pages. |
| European Search Report and Written Opinion dated May 12, 2016 in patent application No. 09746823.5; 11 pages. |
| European Summons to Attend Oral Proceedings and Written Opinion dated Dec. 13, 2017 in patent application No. 09746823,5; 7 pages. |
| European Examination Report in patent application No. 09746823.5, dated Apr. 3, 2017, 2 pages. |
| European Extended Search Report in patent application No. 17179765.7, dated Dec. 11, 2017. |
| European Search Report in patent application No. 11830981.4, dated Aug. 24, 2015, 6 pages. |
| International Search Report for application No. PCT/NZ2005/000062 dated May 27, 2005. |
| International Search Report, PCT/NZ2011/000211, dated Feb. 17, 2012, 4 pages. |
| Written Opinion, PCT/NZ2011/000211, dated Feb. 17, 2012, 7 pages. |
| International Search Report, application No. PCT/NZ2013/000138, dated Nov. 1, 2013, 5 pages. |
| Written Opinion of the international Searching Authority, PCT/NZ2013/000139, dated Nov. 1, 2013. |
| International Search Report for International application No. PCT/NZ2014/000021, filed Feb. 21, 2014. |
| Indian Office Action in Patent Application No. 5250/KOLNP/2008, dated May 23, 2017, 8 pages. |
| Japanese Examination Report in patent application No. 2012-538784, dated Jul. 25, 2016, 2 pages. |
| Japanese Examination Report in patent application No. 2017-040092, dated Feb. 5, 2018. |
| U.S. Appl. No. 61/064,406, 34 pages. |
| U.S. Appl. No. 61/071,893, 43 pages. |
| U.S. Appl. No. 61/136,617, 82 pages. |
| Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,479,741, IPR2016-01714, filed Dec. 14, 2016. |
| Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 37 C.F.R, § 42,108, IPR2016-01714, entered Mar. 10, 2017. |
| Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,479,741, IPR2016-01718, filed Dec. 16, 2016. |
| Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 37 C.F.R. § 42.108, IFR2016-01718, entered Mar. 13, 2017. |
| Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,443,807, IFR2016-01726, filed Dec. 13, 2016. |
| Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 37 C.F.R. § 42.108, IPR2016-01726, entered Mar. 6, 2017. |
| Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,443,807, IPR2016-01734, filed Dec. 22, 2016. |
| Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 37 C.F.R, § 42.108, IFR2016-01734, entered Mar. 13, 2017. |
| U.S. Appl. No. 60/493,515, filed Aug. 8, 2002, Sleeper et al. |
| U.S. Appl. No. 60/496,059, filed Aug. 18, 2003, Ho et al. |
| U.S. Appl. No. 60/529,696, filed Dec. 16, 2003, Lithgow et al. |
| U.S. Appl. No. 61/064,406, filed Mar. 4, 2008, Wehbeh. |
| U.S. Appl. No. 61/071,893, filed May 22, 2008, Wehbeh et al. |
| U.S. Appl. No. 61/136,617, filed Sep. 19, 2008, Wehbeh et al. |
| Resmed Mirage Swift™ II Nasal Pillows System product page (http://www.resmed.com/en-us/products/masks/mirage_swiftII_nasal_pillows.system/Mirage-Swift-II-Nasal-Pillows-System.html?Menu=products); archived Jul. 21, 2008, 2 pp. |
| Resmed Mirage Swift™ II user brochure (http://www.resmed.com/enus/products/masks/mirage-swift_II_nasal_pillows_system/documents/mirage-swift-ii-np-brochure-patient-english-usa.pdf) copyright 2007, 4 pp. |
| ResMed Mirage Swift II Fitting guide (http://www;resmed.com/en-us/products/masks/mirage_swift_IInasal_pillows_system/documents/mirage-swift_ii_np-fitting_English.pdf) copyright 2006, 2 pp. |
| ResMed Mirage Swift II comparison to older Swift patient interface (http://www.resmed.com/en-us/products/masks/mirage_swift_II_nasal_pillows_system/documents/mirage-swift-ii-np-comparison-guide.pdf, 2007, 6 pp. |
| ResMed Mirage Swift II user guide (http://www.resmed.com/en-us/products/service_and_support/documents/60893rl_mirage_swiftII_nasal_userglide_us_multi.pdf) copyright 2006, 1 p. |
| ResMed Mirage Swift II component card (http://www.resmed.com/en-us/products/masks/mirage_swift_II_nasal_pillows_system/documents/mirage-swift-ii-np-cc-usa.pdf); copyright 2006, 2 pp. |
| Resmed Swift™ LT Nasal Pillows System, product page, (http://www.resmed.com/en-us/products/masks/mirage_swift_II_nasal_pillows_system/Mirage-Swift-II-Nasal_Pillows-System.html?menu=products), Jul. 3, 2008, 2 pp. |
| Resmed Swift LT user brochure, (http://www.resmed.com/en-us/products/masks/mirage_swift_II_nasal_pillows_system/documents/mirage-swift-ii-np-brochure-patient-english-usa.pdf), copyright 2008, 4 pp. |
| Resmed Swift™ LT component card (http://www.resmed.com/en-us/assets/documents/product/swift_lt/components_card/1012463_swift-It_components-card_usa_eng.pdf) copyright 2008, 46 pp. |
| Resmed Swift™ LT fitting guide, (http://www.resmed.com/en-us/assets/documents/product/swift-II/clinical_fact_sheet/1012406 swift-ii_fact-sheet_usa_eng.pdf), 2008, 2 pp. |
| Resmed Swift™ LT fact sheet (http://www.resmcd.com/en-us/assets/documents/product/swift-lt/clinical_fact_sheet/1012406swiftlt_fact-sheet_usa_eng.pdf, copyright 2008, 4 pp. |
| Resmed Swift™ LT image gallery (http://www.resmed.com/en-us/products/masks/swift_lt_nasal_pillows_system/imagegallery.html?menu=products, Apr. 25, 2008, 2 pp. |
| Resmed Swift™ LT interactive fitting guide—screenshot from troubleshooting part (http://www.resmed.com/enus/assets/multimedia/product/swift-lt/flash/swift-lt-fitting-eng.swf), Jul. 3, 2008, 2 pp. |
| Puritan Bennett Breeze® SleepGear® CPAP Interface, product page (http:/puritanbennett.com/prod/product.aspx?id=233); archived Oct. 19, 2007, 2 pp. |
| Puritan Bennett Breeze® SleepGear® User's Guide (http://puritanbennett.com_catalog/pdf/dfu/107598a00[I].pdf); copyright 2007, 18 pp. |
| Puritan Bennett Breeze® SleepGear® sales sheet (http://www.puritanbennett.com/_Catalog/PDF/Product/BreezeSleepGear.pdf) copyright 2016, 7 PP. |
| Puritan Bennett mask coding matrix (http://www.puritanbennett.com/_Catalog/PDF/Product/BreezeSlpGear(ST03700).pdf) copyright 2006, 3 pp. |
| Puritan Bennett Breeze fitting guide (http://www.puritanbennett.com/_Catalog/PDF/Product/BreezeFittingPoster.pdf, Oct. 19, 2007, 1 p. |
| Respironics Optilife Pillows mask product page (http://optilife.respironics.com:80/); archived Nov. 21, 2007, 2 pp. |
| Respironics Optilife Pillows mask part numbers page (http://optilife.respironics.com:80/Parts.aspx); archived Nov. 23, 2007, 4 pp. |
| Respironics Optilife Pillows mask FAQ (http;//optilife.respironics.com:80/fags.aspx); archived Nov. 23, 2007, 6 pp. |
| Respironics Optilife Pillows mask feature page (http://opti1ife.respironics.com:80/features.aspx); archived Nov. 23, 2007, 4 pp. |
| Respironics Optilife Pillows mask fitting guide screen shot (http://optilife.respironics.com:80/fittingGuide.aspx); archived Aug. 7, 2008, 1 p. |
| Respironics Optilife Pillows mask adjustment video screenshots, https://www.youtube.com/watch?v=shjcNmwcBA); uploaded Aug. 3, 2008, 2 pp. |
| Puritan Bennett Breeze description; copyright 2000 by Mallinckrodt Inc., 4 pp. |
| Fisher & Paykel Opus product page, archived Sep. 3, 2009, 2 pp. |
| Fisher & Paykel Opus patient interface product photographs, Jul. 2007, 6 pp. |
| Photographs of Opus 360 nasal pillows mask patient instructions RevB, Jul. 2007, 4 pp. |
| Respironics Optilife brochure detailing updates; copyright 2008; dated Mar. 26, 2008, 3 pp. |
| Fisher & Paykel Opus product page, archived Sep. 7, 2009, 2 pp. |
| Fisher & Paykel Opus “Off-the-lips” pillows explanation page, archived Aug. 23, 2009, 2 pp. |
| Fisher & Paykel Opus “Off-the-lips” patient interface brochure, archived Oct. 14, 2009, 6 pp. |
| Fisher & Paykel Opus user-guide, archived Nov. 17, 2009, 2 pp. |
| Australian Examination Report No. 1, in patent application No. AU 2013300237, dated Jun. 8, 2017, in 4 pages. |
| Australian examination report in patent application No. 2018202409, dated Jan. 21, 2019, 4 pages. |
| Canadian Examination Report in patent application No. 2780310, dated Oct. 9, 2018, 3 pp. |
| Canadian Examination Report in patent application No. 2998247, dated Jan. 8, 2019, 4 pages. |
| Chinese Examination Report in patent application No. 201610114706.X, dated Jul. 30, 2018, 9 pp., with translation. |
| European Examination Report, European Application 13828380.9, dated Apr. 7, 2017, 8 pp. |
| European Examination Report, European Application 13828380.9, dated Jul. 27, 2018, 8 pp. |
| European extended search report dated Jul. 23, 2018 in patent application No. 18163847.9, 7 pp. |
| European extended search report dated Sep. 21, 2018 in patent application No. 18178220.2, 7 pp. |
| European extended search report dated Oct. 31, 2018 in patent application No. 18171619.2, 9 pp. |
| Great Britain Combined Search and Examination Report in patent application No. GB1719334.3, dated Nov. 30, 2017, in 9 pages. |
| Great Britain examination report dated May 30, 2018 in patent application No. GB1719334.3, 4 pp. |
| Great Britain examination report dated Jul. 20, 2018 in patent application No. GB1719334.3, 3 pp. |
| Great Britain combined search and examination report dated May 11, 2018 in patent application No. GB1805606.9, 7 pp. |
| Great Britain examination report dated Jul. 5, 2018 in patent application No. GB1805606.9, 3 pp. |
| Great Britain examination report dated May 11, 2018 in patent application No. GB1803255.7, 7 pp. |
| Great Britain examination report dated May 11, 2018 in patent application No. GB1805605.1, 7 pp. |
| Great Britain examination report in patent application No. GB1501499.6, dated Jun. 1, 2017, in 8 pages. |
| Great Britain Combined Search and Examination Report under Section 18(3), Application No. GB1501499.6, dated Oct. 12, 2017, in 4 pages. |
| Japanese Official Action dated Sep. 3, 2018 in patent application No. 2017-238259. |
| Japanese examination report in patent application No. 2015-526496, dated Apr. 17, 2017, in 13 pages. |
| Japanese Examination Report in patent application No. 2015-526496, dated Feb. 28, 2018, 2 pp. |
| Statutory Declaration made by Alistair Edwin McAuley, Apr. 14, 2015, in the matter of an Opposition by Fisher & Paykel Healthcare Limited of Australian patent application 2009221630 in the name of ResMed Limited. |
| Statutory Declaration made by Alistair Edwin McAuley, Apr. 17, 2015, in the matter of an Opposition by Fisher & Paykel Healthcare Limited of Australian patent application 2009221630 in the name of ResMed Limited. |
| Statutory Declaration made by Alistair Edwin McAuley, Sep. 16, 2015, in the matter of an Opposition by Fisher & Paykel Healthcare Limited of Australian patent application 2009221630 in the name of ResMed Limited. |
| First Affidavit of Alistair Edwin McAuley, Dec. 5, 2016, in the matter of Fisher and Paykel Healthcare Limited v. ResMed Limited filed in the Federal Court of Australia. |
| Second Affidavit of Alistair Edwin McAuley, Dec. 21, 2016, in the matter of Fisher and Paykel Healthcare Limited v. ResMed Limited filed in the Federal Court of Australia. |
| Third Affidavit of Alistair Edwin McAuley, Jan 31, 2017, in the matter of Fisher and Paykel Healthcare Limited v. ResMed Limited filed in the Federal Court of Australia, 284 pp. |
| Declaration of Anthony Michael Ging in IPR 2019-000172, IPR 2019-000173, IPR 2019-000177, IPR 2019-000178, dated Nov. 8, 2018, 329 pp. |
| McGraw-Hill Dictionary of Scientific and Technical Terms, Sixth Edition, 2003, Tube, p. 2200. |
| Claim Chart for AirFit P10, U.S. Pat. No. 9,333,315, 3 pp. |
| Number | Date | Country | |
|---|---|---|---|
| 20180221613 A1 | Aug 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61262297 | Nov 2009 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15425145 | Feb 2017 | US |
| Child | 15946391 | US | |
| Parent | 15078970 | Mar 2016 | US |
| Child | 15425145 | US | |
| Parent | 13510468 | US | |
| Child | 15078970 | US |
